JazzyTazzy personal page - To The Moon

JazzyTazzy

JazzyTazzy

No personal profile

13Follow

6Followers

0Topic

0Badge

2022-02-11

Join now!

@TigerEvents:Join Tiger Ski Championship, Win a Bonus of Up to USD 2022

2021-06-12

Let’s go

S&P ekes out gains to close languid week

2021-02-18

Yay!!!

Sorry, the original content has been removed

2021-02-14

Ok

Sanofi's mRNA COVID-19 vaccine candidate not ready this year-CEO

2021-02-13

Wow

Sorry, the original content has been removed

2021-02-12

Up up up

Here's the formula for spotting genuinely undervalued companies, claims this investment house

2021-02-07

Ok

Sorry, the original content has been removed

2021-02-07

Ok

Sorry, the original content has been removed

2021-02-04

Another big player

Sorry, the original content has been removed

2021-02-04

Up

Sorry, the original content has been removed

2021-02-04

Good

Britain trial to test combining Pfizer and AstraZeneca vaccines in two-shot regimen

2021-02-03

Nice

PRESS DIGEST- Financial Times - Feb. 3

2021-01-31

Power of social media

Sorry, the original content has been removed

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3567658644109643","uuid":"3567658644109643","gmtCreate":1604564621332,"gmtModify":1611922363691,"name":"JazzyTazzy","pinyin":"jazzytazzy","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":6,"headSize":13,"tweetSize":22,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.08.05","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-1","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Boss Tiger","description":"The transaction amount of the securities account reaches $100,000","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"60.07%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":4,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":9092109423,"gmtCreate":1644545256524,"gmtModify":1676533939595,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3567658644109643","authorIdStr":"3567658644109643"},"themes":[],"htmlText":"Join now!","listText":"Join now!","text":"Join now!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9092109423","repostId":"9004448317","repostType":1,"repost":{"id":9004448317,"gmtCreate":1642676525258,"gmtModify":1676533734534,"author":{"id":"3527667667103859","authorId":"3527667667103859","name":"TigerEvents","avatar":"https://community-static.tradeup.com/news/c266ef25181ace18bec1262357bbe1a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3527667667103859","authorIdStr":"3527667667103859"},"themes":[],"title":"Join Tiger Ski Championship, Win a Bonus of Up to USD 2022","htmlText":"2022 is the Year of Tiger in Chinese lunar calendar, it’s also a special year for Tiger Brokers. To celebrate the special year, we want to invite you to join the ski game presented by Tiger Brokers specially, and it’s very easy and interesting game for users to play. Join the game and win a bonus of up to USD 2022 and limited-edition Tiger Toys Spring Festival and Winter Olympic are both on the way, open your Tiger Trade App and play the ski game with us, win golden medals as many as you can! You could have chance to try Lucky Draw when you win medals.The more medal you win, the bigger bonus you may win! Big Rewards are as follow: <a href=\"https://www.tigerbrokers.com.sg/activity/market/2022/happy-new-year/#/\" target=\"_blank\">Click to Join the Game</a>","listText":"2022 is the Year of Tiger in Chinese lunar calendar, it’s also a special year for Tiger Brokers. To celebrate the special year, we want to invite you to join the ski game presented by Tiger Brokers specially, and it’s very easy and interesting game for users to play. Join the game and win a bonus of up to USD 2022 and limited-edition Tiger Toys Spring Festival and Winter Olympic are both on the way, open your Tiger Trade App and play the ski game with us, win golden medals as many as you can! You could have chance to try Lucky Draw when you win medals.The more medal you win, the bigger bonus you may win! Big Rewards are as follow: <a href=\"https://www.tigerbrokers.com.sg/activity/market/2022/happy-new-year/#/\" target=\"_blank\">Click to Join the Game</a>","text":"2022 is the Year of Tiger in Chinese lunar calendar, it’s also a special year for Tiger Brokers. To celebrate the special year, we want to invite you to join the ski game presented by Tiger Brokers specially, and it’s very easy and interesting game for users to play. Join the game and win a bonus of up to USD 2022 and limited-edition Tiger Toys Spring Festival and Winter Olympic are both on the way, open your Tiger Trade App and play the ski game with us, win golden medals as many as you can! You could have chance to try Lucky Draw when you win medals.The more medal you win, the bigger bonus you may win! Big Rewards are as follow: Click to Join the Game","images":[{"img":"https://static.tigerbbs.com/a7b44fa056439fb4010fa55e163d27c3","width":"750","height":"1726"}],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9004448317","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":2,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":230,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":188565115,"gmtCreate":1623455571137,"gmtModify":1704203985492,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3567658644109643","authorIdStr":"3567658644109643"},"themes":[],"htmlText":"Let’s go","listText":"Let’s go","text":"Let’s go","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/188565115","repostId":"2142204074","repostType":4,"repost":{"id":"2142204074","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1623441637,"share":"https://ttm.financial/m/news/2142204074?lang=&edition=fundamental","pubTime":"2021-06-12 04:00","market":"us","language":"en","title":"S&P ekes out gains to close languid week","url":"https://stock-news.laohu8.com/highlight/detail?id=2142204074","media":"Reuters","summary":"NEW YORK, June 11  - The S&P 500 closed nominally higher at the end of a torpid week marked with few market-moving catalysts and persistent concerns over whether current inflation spikes could linger and cause the U.S. Federal Reserve to tighten its dovish policy sooner than expected.Economically sensitive smallcaps and transports notched solid gains, outperforming the broader market.For the week, the S&P and the Nasdaq advanced from last Friday's close, while the Dow posted a weekly loss.But th","content":"<p>NEW YORK, June 11 (Reuters) - The S&amp;P 500 closed nominally higher at the end of a torpid week marked with few market-moving catalysts and persistent concerns over whether current inflation spikes could linger and cause the U.S. Federal Reserve to tighten its dovish policy sooner than expected.</p>\n<p>Economically sensitive smallcaps and transports&nbsp;notched solid gains, outperforming the broader market.</p>\n<p>For the week, the S&amp;P and the Nasdaq advanced from last Friday's close, while the Dow posted a weekly loss.</p>\n<p>But the indexes have been range-bound, with few catalysts to move investor sentiment. Much of the focus centered on Thursday's consumer price data, which eased jitters over the duration of the current inflation wave.</p>\n<p>\"It’s a muted day today,\" Oliver Pursche, senior vice president at Wealthspire Advisors, in New York. \"The summer is settling in, people are slipping out of work early and there’s nothing in the news that’s going to materially drive the market in either direction.\"</p>\n<p>\"So, investors are going to wait until earnings season.\"</p>\n<p>The Federal Reserve has repeatedly said that near-term price surges will not metastasize into lasting inflation, an assertion reflected in the University of Michigan's Consumer Sentiment report released on Friday, which showed inflation expectations easing from last month's spike.</p>\n<p>Investors now turn their attention to the Fed's statement at the conclusion of next week's two-day monetary policy meeting, which will be parsed for clues regarding the central bank's timetable for raising key interest rates.</p>\n<p>\"Our view continues to be that inflationary data is transient and we will be around the 2% mark for the year,\" Pursche added.</p>\n<p>Benchmark U.S. Treasury yields posted their biggest weekly drop in nearly a year, weighing on the interest-sensitive financial sector in recent sessions.</p>\n<p>The Food and Drug Administration is facing mounting criticism over its \"accelerated approval\" of Biogen Inc's</p>\n<p>Alzheimer's drug Aduhelm without strong evidence of its ability to combat the disease.</p>\n<p>Biogen shares, along with the broader healthcare sector&nbsp;ended the session lower.</p>\n<p>Unofficially, the Dow Jones Industrial Average rose 14.41 points, or 0.04%, to 34,480.65, the S&amp;P 500 gained 8.29 points, or 0.20%, to 4,247.47 and the Nasdaq Composite&nbsp;added 49.09 points, or 0.35%, to 14,069.42.</p>\n<p>Among the 11 major sectors in the S&amp;P 500, healthcare suffered the biggest percentage drop.</p>\n<p>Much of the trading volume this week was attributable to the ongoing social media-driven \"meme stock\" phenomenon, in which retail investors swarm around heavily shorted stocks.</p>\n<p>But meme stock moves were more muted on Friday, with AMC Entertainment outperforming.</p>\n<p>(Reporting by Stephen Culp in New York Additional reporting by Ambar Warrick and Devik Jain in Bengaluru Editing by Matthew Lewis and Cynthia Osterman)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S&P ekes out gains to close languid week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS&P ekes out gains to close languid week\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-12 04:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>NEW YORK, June 11 (Reuters) - The S&amp;P 500 closed nominally higher at the end of a torpid week marked with few market-moving catalysts and persistent concerns over whether current inflation spikes could linger and cause the U.S. Federal Reserve to tighten its dovish policy sooner than expected.</p>\n<p>Economically sensitive smallcaps and transports&nbsp;notched solid gains, outperforming the broader market.</p>\n<p>For the week, the S&amp;P and the Nasdaq advanced from last Friday's close, while the Dow posted a weekly loss.</p>\n<p>But the indexes have been range-bound, with few catalysts to move investor sentiment. Much of the focus centered on Thursday's consumer price data, which eased jitters over the duration of the current inflation wave.</p>\n<p>\"It’s a muted day today,\" Oliver Pursche, senior vice president at Wealthspire Advisors, in New York. \"The summer is settling in, people are slipping out of work early and there’s nothing in the news that’s going to materially drive the market in either direction.\"</p>\n<p>\"So, investors are going to wait until earnings season.\"</p>\n<p>The Federal Reserve has repeatedly said that near-term price surges will not metastasize into lasting inflation, an assertion reflected in the University of Michigan's Consumer Sentiment report released on Friday, which showed inflation expectations easing from last month's spike.</p>\n<p>Investors now turn their attention to the Fed's statement at the conclusion of next week's two-day monetary policy meeting, which will be parsed for clues regarding the central bank's timetable for raising key interest rates.</p>\n<p>\"Our view continues to be that inflationary data is transient and we will be around the 2% mark for the year,\" Pursche added.</p>\n<p>Benchmark U.S. Treasury yields posted their biggest weekly drop in nearly a year, weighing on the interest-sensitive financial sector in recent sessions.</p>\n<p>The Food and Drug Administration is facing mounting criticism over its \"accelerated approval\" of Biogen Inc's</p>\n<p>Alzheimer's drug Aduhelm without strong evidence of its ability to combat the disease.</p>\n<p>Biogen shares, along with the broader healthcare sector&nbsp;ended the session lower.</p>\n<p>Unofficially, the Dow Jones Industrial Average rose 14.41 points, or 0.04%, to 34,480.65, the S&amp;P 500 gained 8.29 points, or 0.20%, to 4,247.47 and the Nasdaq Composite&nbsp;added 49.09 points, or 0.35%, to 14,069.42.</p>\n<p>Among the 11 major sectors in the S&amp;P 500, healthcare suffered the biggest percentage drop.</p>\n<p>Much of the trading volume this week was attributable to the ongoing social media-driven \"meme stock\" phenomenon, in which retail investors swarm around heavily shorted stocks.</p>\n<p>But meme stock moves were more muted on Friday, with AMC Entertainment outperforming.</p>\n<p>(Reporting by Stephen Culp in New York Additional reporting by Ambar Warrick and Devik Jain in Bengaluru Editing by Matthew Lewis and Cynthia Osterman)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","DJX":"1/100道琼斯","SPXU":"三倍做空标普500ETF","SQQQ":"纳指三倍做空ETF","QLD":"纳指两倍做多ETF","SH":"标普500反向ETF","DXD":"道指两倍做空ETF","PSQ":"纳指反向ETF","DDM":"道指两倍做多ETF","TQQQ":"纳指三倍做多ETF",".DJI":"道琼斯","QQQ":"纳指100ETF","SDS":"两倍做空标普500ETF","DOG":"道指反向ETF",".IXIC":"NASDAQ Composite","SDOW":"道指三倍做空ETF-ProShares",".SPX":"S&P 500 Index","OEX":"标普100","UDOW":"道指三倍做多ETF-ProShares","UPRO":"三倍做多标普500ETF","QID":"纳指两倍做空ETF","OEF":"标普100指数ETF-iShares","IVV":"标普500指数ETF","SSO":"两倍做多标普500ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2142204074","content_text":"NEW YORK, June 11 (Reuters) - The S&P 500 closed nominally higher at the end of a torpid week marked with few market-moving catalysts and persistent concerns over whether current inflation spikes could linger and cause the U.S. Federal Reserve to tighten its dovish policy sooner than expected.\nEconomically sensitive smallcaps and transports notched solid gains, outperforming the broader market.\nFor the week, the S&P and the Nasdaq advanced from last Friday's close, while the Dow posted a weekly loss.\nBut the indexes have been range-bound, with few catalysts to move investor sentiment. Much of the focus centered on Thursday's consumer price data, which eased jitters over the duration of the current inflation wave.\n\"It’s a muted day today,\" Oliver Pursche, senior vice president at Wealthspire Advisors, in New York. \"The summer is settling in, people are slipping out of work early and there’s nothing in the news that’s going to materially drive the market in either direction.\"\n\"So, investors are going to wait until earnings season.\"\nThe Federal Reserve has repeatedly said that near-term price surges will not metastasize into lasting inflation, an assertion reflected in the University of Michigan's Consumer Sentiment report released on Friday, which showed inflation expectations easing from last month's spike.\nInvestors now turn their attention to the Fed's statement at the conclusion of next week's two-day monetary policy meeting, which will be parsed for clues regarding the central bank's timetable for raising key interest rates.\n\"Our view continues to be that inflationary data is transient and we will be around the 2% mark for the year,\" Pursche added.\nBenchmark U.S. Treasury yields posted their biggest weekly drop in nearly a year, weighing on the interest-sensitive financial sector in recent sessions.\nThe Food and Drug Administration is facing mounting criticism over its \"accelerated approval\" of Biogen Inc's\nAlzheimer's drug Aduhelm without strong evidence of its ability to combat the disease.\nBiogen shares, along with the broader healthcare sector ended the session lower.\nUnofficially, the Dow Jones Industrial Average rose 14.41 points, or 0.04%, to 34,480.65, the S&P 500 gained 8.29 points, or 0.20%, to 4,247.47 and the Nasdaq Composite added 49.09 points, or 0.35%, to 14,069.42.\nAmong the 11 major sectors in the S&P 500, healthcare suffered the biggest percentage drop.\nMuch of the trading volume this week was attributable to the ongoing social media-driven \"meme stock\" phenomenon, in which retail investors swarm around heavily shorted stocks.\nBut meme stock moves were more muted on Friday, with AMC Entertainment outperforming.\n(Reporting by Stephen Culp in New York Additional reporting by Ambar Warrick and Devik Jain in Bengaluru Editing by Matthew Lewis and Cynthia Osterman)","news_type":1},"isVote":1,"tweetType":1,"viewCount":581,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":384166185,"gmtCreate":1613627254947,"gmtModify":1704882887562,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3567658644109643","authorIdStr":"3567658644109643"},"themes":[],"htmlText":"Yay!!!","listText":"Yay!!!","text":"Yay!!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":5,"repostSize":0,"link":"https://ttm.financial/post/384166185","repostId":"2112863205","repostType":2,"isVote":1,"tweetType":1,"viewCount":281,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":386469204,"gmtCreate":1613258317708,"gmtModify":1704879570319,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3567658644109643","authorIdStr":"3567658644109643"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/386469204","repostId":"2111807728","repostType":2,"repost":{"id":"2111807728","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1613256424,"share":"https://ttm.financial/m/news/2111807728?lang=&edition=fundamental","pubTime":"2021-02-14 06:47","market":"us","language":"en","title":"Sanofi's mRNA COVID-19 vaccine candidate not ready this year-CEO","url":"https://stock-news.laohu8.com/highlight/detail?id=2111807728","media":"Reuters","summary":"PARIS, Feb 13 (Reuters) - A COVID-19 vaccine candidate developed by Sanofi    and U.S. group Transla","content":"<html><body><p>PARIS, Feb 13 (Reuters) - A COVID-19 vaccine candidate developed by <a href=\"https://laohu8.com/S/GCVRZ\">Sanofi</a>    and U.S. group Translate Bio</p><p>  \"will not be ready this year,\" the French drugmaker's chief executive told Le Journal du Dimanche newspaper.</p><p>   Clinical trials of this vaccine, which will be based on a technology known as mRNA -- on which lean approved vaccines of Pfizer   /BioNTech    and Moderna    --, are expected to start this quarter.</p><p>   In December last year, <a href=\"https://laohu8.com/S/SNYNF\">Sanofi</a> had said it was targeting \"earliest potential approval\" of the shot in the second half of 2021, following positive preclinical data.  </p><p>   \"This vaccine will not be ready this year, but it could be of use at a later stage all the more if the fight against variants was to continue,\" Paul Hudson was quoted as saying.</p><p>   The CEO gave no other details. Officials at Sanofi were not available for comment.</p><p>   The news could mark another blow for Sanofi, already embattled with a delay for another COVID-19 vaccine candidate it hopes to bring to patients and for which the company has teamed up with Britain's GlaxoSmithKline   .</p><p>   The two groups stunned investors last year by warning their traditional, protein-based COVID-19 jab showed an insufficient immune response in older people, delaying its launch towards the end of 2021.  </p><p>   To appease critics, Sanofi said last month it had agreed to fill and pack millions of doses of the Pfizer/BioNTech vaccine from July.  </p><p>   Some 108 million people have been reported to be infected by the novel coronavirus globally and more than 2.4 million have died since first cases were identified in China in December 2019, according to a Reuters tally.</p><p>   Countries worldwide have since the beginning of the year embarked on mass vaccination programmes, with mixed results, and are now confronted with the emergence of several variant strains which forces them to move even more quickly.</p><p> (Reporting by Matthias Blamont; Editing by Dominique Vidalon)</p><p>((matthias.blamont@thomsonreuters.com; +33 1 4949 5054 ; @matthiasblamont))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sanofi's mRNA COVID-19 vaccine candidate not ready this year-CEO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSanofi's mRNA COVID-19 vaccine candidate not ready this year-CEO\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-14 06:47</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>PARIS, Feb 13 (Reuters) - A COVID-19 vaccine candidate developed by <a href=\"https://laohu8.com/S/GCVRZ\">Sanofi</a>    and U.S. group Translate Bio</p><p>  \"will not be ready this year,\" the French drugmaker's chief executive told Le Journal du Dimanche newspaper.</p><p>   Clinical trials of this vaccine, which will be based on a technology known as mRNA -- on which lean approved vaccines of Pfizer   /BioNTech    and Moderna    --, are expected to start this quarter.</p><p>   In December last year, <a href=\"https://laohu8.com/S/SNYNF\">Sanofi</a> had said it was targeting \"earliest potential approval\" of the shot in the second half of 2021, following positive preclinical data.  </p><p>   \"This vaccine will not be ready this year, but it could be of use at a later stage all the more if the fight against variants was to continue,\" Paul Hudson was quoted as saying.</p><p>   The CEO gave no other details. Officials at Sanofi were not available for comment.</p><p>   The news could mark another blow for Sanofi, already embattled with a delay for another COVID-19 vaccine candidate it hopes to bring to patients and for which the company has teamed up with Britain's GlaxoSmithKline   .</p><p>   The two groups stunned investors last year by warning their traditional, protein-based COVID-19 jab showed an insufficient immune response in older people, delaying its launch towards the end of 2021.  </p><p>   To appease critics, Sanofi said last month it had agreed to fill and pack millions of doses of the Pfizer/BioNTech vaccine from July.  </p><p>   Some 108 million people have been reported to be infected by the novel coronavirus globally and more than 2.4 million have died since first cases were identified in China in December 2019, according to a Reuters tally.</p><p>   Countries worldwide have since the beginning of the year embarked on mass vaccination programmes, with mixed results, and are now confronted with the emergence of several variant strains which forces them to move even more quickly.</p><p> (Reporting by Matthias Blamont; Editing by Dominique Vidalon)</p><p>((matthias.blamont@thomsonreuters.com; +33 1 4949 5054 ; @matthiasblamont))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","TBIO":"TELESIS BIO","MRNA":"Moderna, Inc."},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2111807728","content_text":"PARIS, Feb 13 (Reuters) - A COVID-19 vaccine candidate developed by Sanofi    and U.S. group Translate Bio  \"will not be ready this year,\" the French drugmaker's chief executive told Le Journal du Dimanche newspaper.   Clinical trials of this vaccine, which will be based on a technology known as mRNA -- on which lean approved vaccines of Pfizer   /BioNTech    and Moderna    --, are expected to start this quarter.   In December last year, Sanofi had said it was targeting \"earliest potential approval\" of the shot in the second half of 2021, following positive preclinical data.     \"This vaccine will not be ready this year, but it could be of use at a later stage all the more if the fight against variants was to continue,\" Paul Hudson was quoted as saying.   The CEO gave no other details. Officials at Sanofi were not available for comment.   The news could mark another blow for Sanofi, already embattled with a delay for another COVID-19 vaccine candidate it hopes to bring to patients and for which the company has teamed up with Britain's GlaxoSmithKline   .   The two groups stunned investors last year by warning their traditional, protein-based COVID-19 jab showed an insufficient immune response in older people, delaying its launch towards the end of 2021.     To appease critics, Sanofi said last month it had agreed to fill and pack millions of doses of the Pfizer/BioNTech vaccine from July.     Some 108 million people have been reported to be infected by the novel coronavirus globally and more than 2.4 million have died since first cases were identified in China in December 2019, according to a Reuters tally.   Countries worldwide have since the beginning of the year embarked on mass vaccination programmes, with mixed results, and are now confronted with the emergence of several variant strains which forces them to move even more quickly. (Reporting by Matthias Blamont; Editing by Dominique Vidalon)((matthias.blamont@thomsonreuters.com; +33 1 4949 5054 ; @matthiasblamont))","news_type":1},"isVote":1,"tweetType":1,"viewCount":346,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":386631333,"gmtCreate":1613168819622,"gmtModify":1704879132334,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3567658644109643","authorIdStr":"3567658644109643"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/386631333","repostId":"2111071977","repostType":2,"isVote":1,"tweetType":1,"viewCount":402,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":386076859,"gmtCreate":1613121547571,"gmtModify":1704878578795,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3567658644109643","authorIdStr":"3567658644109643"},"themes":[],"htmlText":"Up up up","listText":"Up up up","text":"Up up up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/386076859","repostId":"2110026963","repostType":2,"repost":{"id":"2110026963","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1613109422,"share":"https://ttm.financial/m/news/2110026963?lang=&edition=fundamental","pubTime":"2021-02-12 13:57","market":"us","language":"en","title":"Here's the formula for spotting genuinely undervalued companies, claims this investment house","url":"https://stock-news.laohu8.com/highlight/detail?id=2110026963","media":"Dow Jones","summary":"The growth stock vs. value stock dichotomy doesn't make sense, says ValuAnalysis. For most of 2020, investors poured money into names like online retailer Amazon $$, electric-car maker Tesla $$, and e-commerce platform Shopify -- \"growth\" stocks that kept indexes afloat in a turbulent year that hammered share prices across the board.But when news broke in early November 2020 that drug company Pfizer $$ and its partner BioNTech $$ had developed an effective vaccine against COVID-19, something pro","content":"<p>MW Here's the formula for spotting genuinely undervalued companies, claims this investment house</p>\n<p>The growth stock vs. value stock dichotomy doesn't make sense, says ValuAnalysis</p>\n<p>For most of 2020, investors poured money into names like online retailer Amazon <a href=\"https://laohu8.com/S/AMZN\">$(AMZN)$</a>, electric-car maker Tesla <a href=\"https://laohu8.com/S/TSLA\">$(TSLA)$</a>, and e-commerce platform Shopify (SHOP.T)-- \"growth\" stocks that kept indexes afloat in a turbulent year that hammered share prices across the board.</p>\n<p>But when news broke in early November 2020 that drug company Pfizer <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> and its partner BioNTech <a href=\"https://laohu8.com/S/BNTX\">$(BNTX)$</a> had developed an effective vaccine against COVID-19, something profound happened in financial markets.</p>\n<p>Investors rotated out of these investments in favor of \"value\" stocks hammered by the COVID-19 pandemic, like airlines.</p>\n<p>This rotation was based on an essential concept in investing: There are some stocks that are clearly undervalued based on standard metrics.</p>\n<p>And it is completely flawed, according to research from ValuAnalysis, a London-based fund manager and equity investment boutique, which specializes in valuation.</p>\n<p>The apparent difference between growth stocks and value stocks is that the former is overvalued based on fundamental metrics while the latter is undervalued.</p>\n<p>\"Everyone knows that this thing doesn't make any sense because growth is not the opposite of value,\" Pascal Costantini, who led the research at ValuAnalysis, tells MarketWatch.</p>\n<p>\"It should be high-growth and low-growth, and I can imagine that, somewhere in an office, some guy said 'well this is not catchy enough, so how about growth and value?'\"</p>\n<p>Analysts and investors use metrics like the price-to-earnings ratio, or price multiple, to value stocks. ValuAnalysis uses price as a multiple of normalized net free cash flow as its benchmark, and identifies the imaginary dividing line between value and growth stocks at 35x, which is the market median.</p>\n<p>The value vs. growth divide would suggest that a company trading at a 17x earnings multiple is undervalued. In reality, ValuAnalysis says it is likely a company that won't grow.</p>\n<p>In reality, a stock's value is based on the company's ability to grow free cash flow in an environment where the cost of capital is 5% to 6%. So if a company isn't outpacing that by improving revenue and margins, the multiple won't increase and the stock price is unlikely to rise.</p>\n<p>Stocks that are actually undervalued will trade between 25x and 35x free cash flow, Costantini says, outpacing the cost of capital but not breaking past the market median.</p>\n<p>To have potential, a company's accumulation of assets or revenue growth must outpace increases in global gross domestic product, and ideally show signs of accelerating. There must also be an increase in operational leverage through revenue or margins. A decrease in the risk premium, such as through advances in controlling carbon emissions, helps.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here's the formula for spotting genuinely undervalued companies, claims this investment house</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere's the formula for spotting genuinely undervalued companies, claims this investment house\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-02-12 13:57</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>MW Here's the formula for spotting genuinely undervalued companies, claims this investment house</p>\n<p>The growth stock vs. value stock dichotomy doesn't make sense, says ValuAnalysis</p>\n<p>For most of 2020, investors poured money into names like online retailer Amazon <a href=\"https://laohu8.com/S/AMZN\">$(AMZN)$</a>, electric-car maker Tesla <a href=\"https://laohu8.com/S/TSLA\">$(TSLA)$</a>, and e-commerce platform Shopify (SHOP.T)-- \"growth\" stocks that kept indexes afloat in a turbulent year that hammered share prices across the board.</p>\n<p>But when news broke in early November 2020 that drug company Pfizer <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> and its partner BioNTech <a href=\"https://laohu8.com/S/BNTX\">$(BNTX)$</a> had developed an effective vaccine against COVID-19, something profound happened in financial markets.</p>\n<p>Investors rotated out of these investments in favor of \"value\" stocks hammered by the COVID-19 pandemic, like airlines.</p>\n<p>This rotation was based on an essential concept in investing: There are some stocks that are clearly undervalued based on standard metrics.</p>\n<p>And it is completely flawed, according to research from ValuAnalysis, a London-based fund manager and equity investment boutique, which specializes in valuation.</p>\n<p>The apparent difference between growth stocks and value stocks is that the former is overvalued based on fundamental metrics while the latter is undervalued.</p>\n<p>\"Everyone knows that this thing doesn't make any sense because growth is not the opposite of value,\" Pascal Costantini, who led the research at ValuAnalysis, tells MarketWatch.</p>\n<p>\"It should be high-growth and low-growth, and I can imagine that, somewhere in an office, some guy said 'well this is not catchy enough, so how about growth and value?'\"</p>\n<p>Analysts and investors use metrics like the price-to-earnings ratio, or price multiple, to value stocks. ValuAnalysis uses price as a multiple of normalized net free cash flow as its benchmark, and identifies the imaginary dividing line between value and growth stocks at 35x, which is the market median.</p>\n<p>The value vs. growth divide would suggest that a company trading at a 17x earnings multiple is undervalued. In reality, ValuAnalysis says it is likely a company that won't grow.</p>\n<p>In reality, a stock's value is based on the company's ability to grow free cash flow in an environment where the cost of capital is 5% to 6%. So if a company isn't outpacing that by improving revenue and margins, the multiple won't increase and the stock price is unlikely to rise.</p>\n<p>Stocks that are actually undervalued will trade between 25x and 35x free cash flow, Costantini says, outpacing the cost of capital but not breaking past the market median.</p>\n<p>To have potential, a company's accumulation of assets or revenue growth must outpace increases in global gross domestic product, and ideally show signs of accelerating. There must also be an increase in operational leverage through revenue or margins. A decrease in the risk premium, such as through advances in controlling carbon emissions, helps.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/15e20574f8fb568333181d61bb200086","relate_stocks":{"TSLA":"特斯拉","AMZN":"亚马逊","PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2110026963","content_text":"MW Here's the formula for spotting genuinely undervalued companies, claims this investment house\nThe growth stock vs. value stock dichotomy doesn't make sense, says ValuAnalysis\nFor most of 2020, investors poured money into names like online retailer Amazon $(AMZN)$, electric-car maker Tesla $(TSLA)$, and e-commerce platform Shopify (SHOP.T)-- \"growth\" stocks that kept indexes afloat in a turbulent year that hammered share prices across the board.\nBut when news broke in early November 2020 that drug company Pfizer $(PFE)$ and its partner BioNTech $(BNTX)$ had developed an effective vaccine against COVID-19, something profound happened in financial markets.\nInvestors rotated out of these investments in favor of \"value\" stocks hammered by the COVID-19 pandemic, like airlines.\nThis rotation was based on an essential concept in investing: There are some stocks that are clearly undervalued based on standard metrics.\nAnd it is completely flawed, according to research from ValuAnalysis, a London-based fund manager and equity investment boutique, which specializes in valuation.\nThe apparent difference between growth stocks and value stocks is that the former is overvalued based on fundamental metrics while the latter is undervalued.\n\"Everyone knows that this thing doesn't make any sense because growth is not the opposite of value,\" Pascal Costantini, who led the research at ValuAnalysis, tells MarketWatch.\n\"It should be high-growth and low-growth, and I can imagine that, somewhere in an office, some guy said 'well this is not catchy enough, so how about growth and value?'\"\nAnalysts and investors use metrics like the price-to-earnings ratio, or price multiple, to value stocks. ValuAnalysis uses price as a multiple of normalized net free cash flow as its benchmark, and identifies the imaginary dividing line between value and growth stocks at 35x, which is the market median.\nThe value vs. growth divide would suggest that a company trading at a 17x earnings multiple is undervalued. In reality, ValuAnalysis says it is likely a company that won't grow.\nIn reality, a stock's value is based on the company's ability to grow free cash flow in an environment where the cost of capital is 5% to 6%. So if a company isn't outpacing that by improving revenue and margins, the multiple won't increase and the stock price is unlikely to rise.\nStocks that are actually undervalued will trade between 25x and 35x free cash flow, Costantini says, outpacing the cost of capital but not breaking past the market median.\nTo have potential, a company's accumulation of assets or revenue growth must outpace increases in global gross domestic product, and ideally show signs of accelerating. There must also be an increase in operational leverage through revenue or margins. A decrease in the risk premium, such as through advances in controlling carbon emissions, helps.","news_type":1},"isVote":1,"tweetType":1,"viewCount":368,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":389370214,"gmtCreate":1612702161938,"gmtModify":1704873577730,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3567658644109643","authorIdStr":"3567658644109643"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/389370214","repostId":"2109704729","repostType":2,"isVote":1,"tweetType":1,"viewCount":313,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":389370655,"gmtCreate":1612702142177,"gmtModify":1704873577895,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3567658644109643","authorIdStr":"3567658644109643"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/389370655","repostId":"2109704729","repostType":2,"isVote":1,"tweetType":1,"viewCount":526,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":317022586,"gmtCreate":1612400076245,"gmtModify":1704870637343,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3567658644109643","authorIdStr":"3567658644109643"},"themes":[],"htmlText":"Another big player","listText":"Another big player","text":"Another big player","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/317022586","repostId":"2108795093","repostType":2,"isVote":1,"tweetType":1,"viewCount":810,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":317022073,"gmtCreate":1612400045493,"gmtModify":1704870636210,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3567658644109643","authorIdStr":"3567658644109643"},"themes":[],"htmlText":"Up","listText":"Up","text":"Up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/317022073","repostId":"2108579668","repostType":2,"isVote":1,"tweetType":1,"viewCount":498,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":317026310,"gmtCreate":1612400012630,"gmtModify":1704870635210,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3567658644109643","authorIdStr":"3567658644109643"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/317026310","repostId":"2108796672","repostType":2,"repost":{"id":"2108796672","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1612396860,"share":"https://ttm.financial/m/news/2108796672?lang=&edition=fundamental","pubTime":"2021-02-04 08:01","market":"us","language":"en","title":"Britain trial to test combining Pfizer and AstraZeneca vaccines in two-shot regimen","url":"https://stock-news.laohu8.com/highlight/detail?id=2108796672","media":"Reuters","summary":"LONDON, Feb 4 (Reuters) - Britain on Thursday launched a trial to assess the immune responses genera","content":"<html><body><p>LONDON, Feb 4 (Reuters) - Britain on Thursday launched a trial to assess the immune responses generated if doses of the COVID-19 vaccines from Pfizer Inc    and <a href=\"https://laohu8.com/S/AZNCF\">AstraZeneca Plc</a></p><p>  are combined in a two-shot schedule.    </p><p>   The British researchers behind the trial said data on vaccinating people with the two different types of coronavirus vaccines could help understanding of whether shots can be rolled out with greater flexibility around the world. Initial data on immune responses is expected to be generated around June.    </p><p>   The trial will examine the immune responses of an initial dose of Pfizer vaccine followed by a booster of AstraZeneca's, as well as vice versa, with intervals of 4 and 12 weeks. </p><p>   Both the mRNA shot developed by Pfizer and Biontech    and the adenovirus viral vector vaccine developed by Oxford University and AstraZeneca are currently being rolled out in Britain, with a 12-week gap between two doses of the same vaccine. </p><p>   It is expected more vaccines will be added to the trial when they are approved and rolled out.</p><p>   Recruitment for the study starts on Thursday, with over 800 participants expected to take part, the researchers said. That makes it much smaller than the clinical trials that have been used to determine efficacy of the vaccines individually.</p><p>   The trial will not assess the overall efficacy of the shot combinations, but researchers will measure antibody and T-cell responses, as well as monitor for any unexpected side effects.</p><p>   Matthew Snape, an Oxford vaccinologist who is leading the trial, said initial results could inform vaccine deployment in the second half of the year.</p><p>   \"We will get some results through, we expect, by June or thereabouts that will inform the use of booster doses in the general population,\" he told reporters.</p><p>   The trial is looking to recruit people over the age of 50 who may be at higher risk than younger people and have not been vaccinated already.</p><p>   AstraZeneca's shot is also being tested in combination with Russia's Sputnik V vaccine, and British drugmaker's research chief has said more studies on combining vaccines should be done.  </p><p> (Reporting by Alistair Smout Editing by Bill Berkrot)</p><p>((alistair.smout@thomsonreuters.com; +44 207 542 7064; Reuters Messaging: alistair.smout.thomsonreuters.com@reuters.net))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Britain trial to test combining Pfizer and AstraZeneca vaccines in two-shot regimen</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBritain trial to test combining Pfizer and AstraZeneca vaccines in two-shot regimen\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-04 08:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>LONDON, Feb 4 (Reuters) - Britain on Thursday launched a trial to assess the immune responses generated if doses of the COVID-19 vaccines from Pfizer Inc    and <a href=\"https://laohu8.com/S/AZNCF\">AstraZeneca Plc</a></p><p>  are combined in a two-shot schedule.    </p><p>   The British researchers behind the trial said data on vaccinating people with the two different types of coronavirus vaccines could help understanding of whether shots can be rolled out with greater flexibility around the world. Initial data on immune responses is expected to be generated around June.    </p><p>   The trial will examine the immune responses of an initial dose of Pfizer vaccine followed by a booster of AstraZeneca's, as well as vice versa, with intervals of 4 and 12 weeks. </p><p>   Both the mRNA shot developed by Pfizer and Biontech    and the adenovirus viral vector vaccine developed by Oxford University and AstraZeneca are currently being rolled out in Britain, with a 12-week gap between two doses of the same vaccine. </p><p>   It is expected more vaccines will be added to the trial when they are approved and rolled out.</p><p>   Recruitment for the study starts on Thursday, with over 800 participants expected to take part, the researchers said. That makes it much smaller than the clinical trials that have been used to determine efficacy of the vaccines individually.</p><p>   The trial will not assess the overall efficacy of the shot combinations, but researchers will measure antibody and T-cell responses, as well as monitor for any unexpected side effects.</p><p>   Matthew Snape, an Oxford vaccinologist who is leading the trial, said initial results could inform vaccine deployment in the second half of the year.</p><p>   \"We will get some results through, we expect, by June or thereabouts that will inform the use of booster doses in the general population,\" he told reporters.</p><p>   The trial is looking to recruit people over the age of 50 who may be at higher risk than younger people and have not been vaccinated already.</p><p>   AstraZeneca's shot is also being tested in combination with Russia's Sputnik V vaccine, and British drugmaker's research chief has said more studies on combining vaccines should be done.  </p><p> (Reporting by Alistair Smout Editing by Bill Berkrot)</p><p>((alistair.smout@thomsonreuters.com; +44 207 542 7064; Reuters Messaging: alistair.smout.thomsonreuters.com@reuters.net))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2108796672","content_text":"LONDON, Feb 4 (Reuters) - Britain on Thursday launched a trial to assess the immune responses generated if doses of the COVID-19 vaccines from Pfizer Inc    and AstraZeneca Plc  are combined in a two-shot schedule.       The British researchers behind the trial said data on vaccinating people with the two different types of coronavirus vaccines could help understanding of whether shots can be rolled out with greater flexibility around the world. Initial data on immune responses is expected to be generated around June.       The trial will examine the immune responses of an initial dose of Pfizer vaccine followed by a booster of AstraZeneca's, as well as vice versa, with intervals of 4 and 12 weeks.    Both the mRNA shot developed by Pfizer and Biontech    and the adenovirus viral vector vaccine developed by Oxford University and AstraZeneca are currently being rolled out in Britain, with a 12-week gap between two doses of the same vaccine.    It is expected more vaccines will be added to the trial when they are approved and rolled out.   Recruitment for the study starts on Thursday, with over 800 participants expected to take part, the researchers said. That makes it much smaller than the clinical trials that have been used to determine efficacy of the vaccines individually.   The trial will not assess the overall efficacy of the shot combinations, but researchers will measure antibody and T-cell responses, as well as monitor for any unexpected side effects.   Matthew Snape, an Oxford vaccinologist who is leading the trial, said initial results could inform vaccine deployment in the second half of the year.   \"We will get some results through, we expect, by June or thereabouts that will inform the use of booster doses in the general population,\" he told reporters.   The trial is looking to recruit people over the age of 50 who may be at higher risk than younger people and have not been vaccinated already.   AstraZeneca's shot is also being tested in combination with Russia's Sputnik V vaccine, and British drugmaker's research chief has said more studies on combining vaccines should be done.   (Reporting by Alistair Smout Editing by Bill Berkrot)((alistair.smout@thomsonreuters.com; +44 207 542 7064; Reuters Messaging: alistair.smout.thomsonreuters.com@reuters.net))","news_type":1},"isVote":1,"tweetType":1,"viewCount":358,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":314102811,"gmtCreate":1612316052533,"gmtModify":1704869629957,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3567658644109643","authorIdStr":"3567658644109643"},"themes":[],"htmlText":"Nice&nbsp;","listText":"Nice&nbsp;","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/314102811","repostId":"2108275853","repostType":2,"repost":{"id":"2108275853","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1612313204,"share":"https://ttm.financial/m/news/2108275853?lang=&edition=fundamental","pubTime":"2021-02-03 08:46","market":"us","language":"en","title":"PRESS DIGEST- Financial Times - Feb. 3","url":"https://stock-news.laohu8.com/highlight/detail?id=2108275853","media":"Reuters","summary":"Feb 3 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified","content":"<html><body><p>Feb 3 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.</p><p>   Headlines</p><p>   UK starts process to form post-Brexit state-aid watchdog </p><p>   Amazon's Jeff Bezos to step aside as chief executive this year </p><p>   Oxford/AstraZeneca study supports UK decision to delay second doses </p><p>   Steve Cohen's Point72 raises $1.5bn </p><p>   Overview</p><p>   Britain will take an important step towards the creation of an independent authority to oversee its post-Brexit subsidy regime on Wednesday when it launches a consultation on how the new body will operate and whether it should have enforcement powers.</p><p>   Amazon.com Inc    said on Tuesday chief executive Jeff Bezos will step aside later this year to become executive chairman, making way for cloud computing division head Andy Jassy to replace him in the role.</p><p>   A single dose of the Oxford and AstraZeneca coronavirus vaccine is 76% effective from three weeks to 12 weeks after the injection, according to an analysis of trial data.</p><p>    Billionaire investor Steven Cohen's Point72 Asset Management has raised $1.5 billion from investors, boosting the hedge fund's assets under management after it lost 10% in January and provided emergency financing to Melvin Capital, the firm at the centre of the GameStop    short squeeze.</p><p> (Compiled by Bengaluru newsroom)</p><p>((globalnewsmonitoring@thomsonreuters.com))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>PRESS DIGEST- Financial Times - Feb. 3</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPRESS DIGEST- Financial Times - Feb. 3\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-03 08:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>Feb 3 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.</p><p>   Headlines</p><p>   UK starts process to form post-Brexit state-aid watchdog </p><p>   Amazon's Jeff Bezos to step aside as chief executive this year </p><p>   Oxford/AstraZeneca study supports UK decision to delay second doses </p><p>   Steve Cohen's Point72 raises $1.5bn </p><p>   Overview</p><p>   Britain will take an important step towards the creation of an independent authority to oversee its post-Brexit subsidy regime on Wednesday when it launches a consultation on how the new body will operate and whether it should have enforcement powers.</p><p>   Amazon.com Inc    said on Tuesday chief executive Jeff Bezos will step aside later this year to become executive chairman, making way for cloud computing division head Andy Jassy to replace him in the role.</p><p>   A single dose of the Oxford and AstraZeneca coronavirus vaccine is 76% effective from three weeks to 12 weeks after the injection, according to an analysis of trial data.</p><p>    Billionaire investor Steven Cohen's Point72 Asset Management has raised $1.5 billion from investors, boosting the hedge fund's assets under management after it lost 10% in January and provided emergency financing to Melvin Capital, the firm at the centre of the GameStop    short squeeze.</p><p> (Compiled by Bengaluru newsroom)</p><p>((globalnewsmonitoring@thomsonreuters.com))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"09086":"华夏纳指-U","QNETCN":"纳斯达克中美互联网老虎指数","03086":"华夏纳指","AMZN":"亚马逊"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2108275853","content_text":"Feb 3 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.   Headlines   UK starts process to form post-Brexit state-aid watchdog    Amazon's Jeff Bezos to step aside as chief executive this year    Oxford/AstraZeneca study supports UK decision to delay second doses    Steve Cohen's Point72 raises $1.5bn    Overview   Britain will take an important step towards the creation of an independent authority to oversee its post-Brexit subsidy regime on Wednesday when it launches a consultation on how the new body will operate and whether it should have enforcement powers.   Amazon.com Inc    said on Tuesday chief executive Jeff Bezos will step aside later this year to become executive chairman, making way for cloud computing division head Andy Jassy to replace him in the role.   A single dose of the Oxford and AstraZeneca coronavirus vaccine is 76% effective from three weeks to 12 weeks after the injection, according to an analysis of trial data.    Billionaire investor Steven Cohen's Point72 Asset Management has raised $1.5 billion from investors, boosting the hedge fund's assets under management after it lost 10% in January and provided emergency financing to Melvin Capital, the firm at the centre of the GameStop    short squeeze. (Compiled by Bengaluru newsroom)((globalnewsmonitoring@thomsonreuters.com))","news_type":1},"isVote":1,"tweetType":1,"viewCount":143,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":312354759,"gmtCreate":1612050217671,"gmtModify":1704867018105,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3567658644109643","authorIdStr":"3567658644109643"},"themes":[],"htmlText":"Power of social media","listText":"Power of social media","text":"Power of social media","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/312354759","repostId":"2107223679","repostType":2,"isVote":1,"tweetType":1,"viewCount":195,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":384166185,"gmtCreate":1613627254947,"gmtModify":1704882887562,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567658644109643","idStr":"3567658644109643"},"themes":[],"htmlText":"Yay!!!","listText":"Yay!!!","text":"Yay!!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":5,"repostSize":0,"link":"https://ttm.financial/post/384166185","repostId":"2112863205","repostType":2,"repost":{"id":"2112863205","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1613625832,"share":"https://ttm.financial/m/news/2112863205?lang=&edition=fundamental","pubTime":"2021-02-18 13:23","market":"us","language":"en","title":"Tesla reduces price of base variant of Model 3 and Model Y","url":"https://stock-news.laohu8.com/highlight/detail?id=2112863205","media":"Reuters","summary":"Feb 18 (Reuters) - Tesla reduced the price of its base models of Model 3 and Model Y cars, according to the company's website.\n\n\nTesla lowered the prices of its Model 3 Standard Range Plus to $36,990 and Model Y Standard Range Plus to $39,990.","content":"<p>Feb 18 (Reuters) - Tesla reduced the price of its base models of Model 3 and Model Y cars, according to the company's website.</p>\n<p>Tesla lowered the prices of its Model 3 Standard Range Plus to $36,990 and Model Y Standard Range Plus to $39,990.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla reduces price of base variant of Model 3 and Model Y</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla reduces price of base variant of Model 3 and Model Y\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-18 13:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Feb 18 (Reuters) - Tesla reduced the price of its base models of Model 3 and Model Y cars, according to the company's website.</p>\n<p>Tesla lowered the prices of its Model 3 Standard Range Plus to $36,990 and Model Y Standard Range Plus to $39,990.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2112863205","content_text":"Feb 18 (Reuters) - Tesla reduced the price of its base models of Model 3 and Model Y cars, according to the company's website.\nTesla lowered the prices of its Model 3 Standard Range Plus to $36,990 and Model Y Standard Range Plus to $39,990.","news_type":1},"isVote":1,"tweetType":1,"viewCount":281,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":188565115,"gmtCreate":1623455571137,"gmtModify":1704203985492,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567658644109643","idStr":"3567658644109643"},"themes":[],"htmlText":"Let’s go","listText":"Let’s go","text":"Let’s go","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/188565115","repostId":"2142204074","repostType":4,"repost":{"id":"2142204074","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1623441637,"share":"https://ttm.financial/m/news/2142204074?lang=&edition=fundamental","pubTime":"2021-06-12 04:00","market":"us","language":"en","title":"S&P ekes out gains to close languid week","url":"https://stock-news.laohu8.com/highlight/detail?id=2142204074","media":"Reuters","summary":"NEW YORK, June 11  - The S&P 500 closed nominally higher at the end of a torpid week marked with few market-moving catalysts and persistent concerns over whether current inflation spikes could linger and cause the U.S. Federal Reserve to tighten its dovish policy sooner than expected.Economically sensitive smallcaps and transports notched solid gains, outperforming the broader market.For the week, the S&P and the Nasdaq advanced from last Friday's close, while the Dow posted a weekly loss.But th","content":"<p>NEW YORK, June 11 (Reuters) - The S&amp;P 500 closed nominally higher at the end of a torpid week marked with few market-moving catalysts and persistent concerns over whether current inflation spikes could linger and cause the U.S. Federal Reserve to tighten its dovish policy sooner than expected.</p>\n<p>Economically sensitive smallcaps and transports&nbsp;notched solid gains, outperforming the broader market.</p>\n<p>For the week, the S&amp;P and the Nasdaq advanced from last Friday's close, while the Dow posted a weekly loss.</p>\n<p>But the indexes have been range-bound, with few catalysts to move investor sentiment. Much of the focus centered on Thursday's consumer price data, which eased jitters over the duration of the current inflation wave.</p>\n<p>\"It’s a muted day today,\" Oliver Pursche, senior vice president at Wealthspire Advisors, in New York. \"The summer is settling in, people are slipping out of work early and there’s nothing in the news that’s going to materially drive the market in either direction.\"</p>\n<p>\"So, investors are going to wait until earnings season.\"</p>\n<p>The Federal Reserve has repeatedly said that near-term price surges will not metastasize into lasting inflation, an assertion reflected in the University of Michigan's Consumer Sentiment report released on Friday, which showed inflation expectations easing from last month's spike.</p>\n<p>Investors now turn their attention to the Fed's statement at the conclusion of next week's two-day monetary policy meeting, which will be parsed for clues regarding the central bank's timetable for raising key interest rates.</p>\n<p>\"Our view continues to be that inflationary data is transient and we will be around the 2% mark for the year,\" Pursche added.</p>\n<p>Benchmark U.S. Treasury yields posted their biggest weekly drop in nearly a year, weighing on the interest-sensitive financial sector in recent sessions.</p>\n<p>The Food and Drug Administration is facing mounting criticism over its \"accelerated approval\" of Biogen Inc's</p>\n<p>Alzheimer's drug Aduhelm without strong evidence of its ability to combat the disease.</p>\n<p>Biogen shares, along with the broader healthcare sector&nbsp;ended the session lower.</p>\n<p>Unofficially, the Dow Jones Industrial Average rose 14.41 points, or 0.04%, to 34,480.65, the S&amp;P 500 gained 8.29 points, or 0.20%, to 4,247.47 and the Nasdaq Composite&nbsp;added 49.09 points, or 0.35%, to 14,069.42.</p>\n<p>Among the 11 major sectors in the S&amp;P 500, healthcare suffered the biggest percentage drop.</p>\n<p>Much of the trading volume this week was attributable to the ongoing social media-driven \"meme stock\" phenomenon, in which retail investors swarm around heavily shorted stocks.</p>\n<p>But meme stock moves were more muted on Friday, with AMC Entertainment outperforming.</p>\n<p>(Reporting by Stephen Culp in New York Additional reporting by Ambar Warrick and Devik Jain in Bengaluru Editing by Matthew Lewis and Cynthia Osterman)</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S&P ekes out gains to close languid week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS&P ekes out gains to close languid week\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-12 04:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>NEW YORK, June 11 (Reuters) - The S&amp;P 500 closed nominally higher at the end of a torpid week marked with few market-moving catalysts and persistent concerns over whether current inflation spikes could linger and cause the U.S. Federal Reserve to tighten its dovish policy sooner than expected.</p>\n<p>Economically sensitive smallcaps and transports&nbsp;notched solid gains, outperforming the broader market.</p>\n<p>For the week, the S&amp;P and the Nasdaq advanced from last Friday's close, while the Dow posted a weekly loss.</p>\n<p>But the indexes have been range-bound, with few catalysts to move investor sentiment. Much of the focus centered on Thursday's consumer price data, which eased jitters over the duration of the current inflation wave.</p>\n<p>\"It’s a muted day today,\" Oliver Pursche, senior vice president at Wealthspire Advisors, in New York. \"The summer is settling in, people are slipping out of work early and there’s nothing in the news that’s going to materially drive the market in either direction.\"</p>\n<p>\"So, investors are going to wait until earnings season.\"</p>\n<p>The Federal Reserve has repeatedly said that near-term price surges will not metastasize into lasting inflation, an assertion reflected in the University of Michigan's Consumer Sentiment report released on Friday, which showed inflation expectations easing from last month's spike.</p>\n<p>Investors now turn their attention to the Fed's statement at the conclusion of next week's two-day monetary policy meeting, which will be parsed for clues regarding the central bank's timetable for raising key interest rates.</p>\n<p>\"Our view continues to be that inflationary data is transient and we will be around the 2% mark for the year,\" Pursche added.</p>\n<p>Benchmark U.S. Treasury yields posted their biggest weekly drop in nearly a year, weighing on the interest-sensitive financial sector in recent sessions.</p>\n<p>The Food and Drug Administration is facing mounting criticism over its \"accelerated approval\" of Biogen Inc's</p>\n<p>Alzheimer's drug Aduhelm without strong evidence of its ability to combat the disease.</p>\n<p>Biogen shares, along with the broader healthcare sector&nbsp;ended the session lower.</p>\n<p>Unofficially, the Dow Jones Industrial Average rose 14.41 points, or 0.04%, to 34,480.65, the S&amp;P 500 gained 8.29 points, or 0.20%, to 4,247.47 and the Nasdaq Composite&nbsp;added 49.09 points, or 0.35%, to 14,069.42.</p>\n<p>Among the 11 major sectors in the S&amp;P 500, healthcare suffered the biggest percentage drop.</p>\n<p>Much of the trading volume this week was attributable to the ongoing social media-driven \"meme stock\" phenomenon, in which retail investors swarm around heavily shorted stocks.</p>\n<p>But meme stock moves were more muted on Friday, with AMC Entertainment outperforming.</p>\n<p>(Reporting by Stephen Culp in New York Additional reporting by Ambar Warrick and Devik Jain in Bengaluru Editing by Matthew Lewis and Cynthia Osterman)</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","513500":"标普500ETF","DJX":"1/100道琼斯","SPXU":"三倍做空标普500ETF","SQQQ":"纳指三倍做空ETF","QLD":"纳指两倍做多ETF","SH":"标普500反向ETF","DXD":"道指两倍做空ETF","PSQ":"纳指反向ETF","DDM":"道指两倍做多ETF","TQQQ":"纳指三倍做多ETF",".DJI":"道琼斯","QQQ":"纳指100ETF","SDS":"两倍做空标普500ETF","DOG":"道指反向ETF",".IXIC":"NASDAQ Composite","SDOW":"道指三倍做空ETF-ProShares",".SPX":"S&P 500 Index","OEX":"标普100","UDOW":"道指三倍做多ETF-ProShares","UPRO":"三倍做多标普500ETF","QID":"纳指两倍做空ETF","OEF":"标普100指数ETF-iShares","IVV":"标普500指数ETF","SSO":"两倍做多标普500ETF"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2142204074","content_text":"NEW YORK, June 11 (Reuters) - The S&P 500 closed nominally higher at the end of a torpid week marked with few market-moving catalysts and persistent concerns over whether current inflation spikes could linger and cause the U.S. Federal Reserve to tighten its dovish policy sooner than expected.\nEconomically sensitive smallcaps and transports notched solid gains, outperforming the broader market.\nFor the week, the S&P and the Nasdaq advanced from last Friday's close, while the Dow posted a weekly loss.\nBut the indexes have been range-bound, with few catalysts to move investor sentiment. Much of the focus centered on Thursday's consumer price data, which eased jitters over the duration of the current inflation wave.\n\"It’s a muted day today,\" Oliver Pursche, senior vice president at Wealthspire Advisors, in New York. \"The summer is settling in, people are slipping out of work early and there’s nothing in the news that’s going to materially drive the market in either direction.\"\n\"So, investors are going to wait until earnings season.\"\nThe Federal Reserve has repeatedly said that near-term price surges will not metastasize into lasting inflation, an assertion reflected in the University of Michigan's Consumer Sentiment report released on Friday, which showed inflation expectations easing from last month's spike.\nInvestors now turn their attention to the Fed's statement at the conclusion of next week's two-day monetary policy meeting, which will be parsed for clues regarding the central bank's timetable for raising key interest rates.\n\"Our view continues to be that inflationary data is transient and we will be around the 2% mark for the year,\" Pursche added.\nBenchmark U.S. Treasury yields posted their biggest weekly drop in nearly a year, weighing on the interest-sensitive financial sector in recent sessions.\nThe Food and Drug Administration is facing mounting criticism over its \"accelerated approval\" of Biogen Inc's\nAlzheimer's drug Aduhelm without strong evidence of its ability to combat the disease.\nBiogen shares, along with the broader healthcare sector ended the session lower.\nUnofficially, the Dow Jones Industrial Average rose 14.41 points, or 0.04%, to 34,480.65, the S&P 500 gained 8.29 points, or 0.20%, to 4,247.47 and the Nasdaq Composite added 49.09 points, or 0.35%, to 14,069.42.\nAmong the 11 major sectors in the S&P 500, healthcare suffered the biggest percentage drop.\nMuch of the trading volume this week was attributable to the ongoing social media-driven \"meme stock\" phenomenon, in which retail investors swarm around heavily shorted stocks.\nBut meme stock moves were more muted on Friday, with AMC Entertainment outperforming.\n(Reporting by Stephen Culp in New York Additional reporting by Ambar Warrick and Devik Jain in Bengaluru Editing by Matthew Lewis and Cynthia Osterman)","news_type":1},"isVote":1,"tweetType":1,"viewCount":581,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":312354759,"gmtCreate":1612050217671,"gmtModify":1704867018105,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567658644109643","idStr":"3567658644109643"},"themes":[],"htmlText":"Power of social media","listText":"Power of social media","text":"Power of social media","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/312354759","repostId":"2107223679","repostType":2,"repost":{"id":"2107223679","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1612044660,"share":"https://ttm.financial/m/news/2107223679?lang=&edition=fundamental","pubTime":"2021-01-31 06:11","market":"us","language":"en","title":"How you could lose everything by short-selling stocks, whether it's betting against GameStop or Tesla","url":"https://stock-news.laohu8.com/highlight/detail?id=2107223679","media":"Dow Jones","summary":"MW UPDATE: How you could lose everything by short-selling stocks, whether it's betting against GameS","content":"<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nMW UPDATE: How you could lose everything by short-selling stocks, whether it's betting against GameStop or Tesla\n</p>\n<p>\n  By Philip van Doorn \n</p>\n<p>\n  GameStop short-sellers are blowing up professional investors' funds. But the story is far different for bets against Tesla and other large-cap stocks. \n</p>\n<p>\n  The wild ride for GameStop Corp.'s stock illustrates the power of social media to force short-sellers -- even professional investors -- to give up on their positions and book heavy losses. But talk of individual investors \"breaking\" the mechanics of the stock market may be premature. \n</p>\n<p>\n  Among the S&amp;P Composite 1500, GameStop is the  most heavily shorted stock as a percentage of shares available for sale, according to  FactSet, which updates the numbers twice a month. The most heavily shorted stock in dollars is Tesla Inc. <a href=\"https://laohu8.com/S/TSLA\">$(TSLA)$</a>. \n</p>\n<p>\n  Tesla and other large companies, including Amazon.com Inc. <a href=\"https://laohu8.com/S/AMZN\">$(AMZN)$</a> and Apple Inc. <a href=\"https://laohu8.com/S/AAPL\">$(AAPL)$</a>, have tens of billions of dollars in short sales against their stocks. Those bets center around hedge funds and other professional investors making much bigger wagers than the ones against GameStop. \n</p>\n<p>\n  \"I have never see anybody rush the capital markets like they did [into GameStop's shares], and it could not have occurred without social media. The public has gotten so much more involved in individual stocks that they are overwhelming the professionals right now, in these small- and mid-cap stocks. Not in Tesla,\" said Brad Lamensdorf, CEO of ActiveAlts in Westport, Conn., who runs long and short investment strategies. \n</p>\n<p>\n  Regardless, GameStop's action illustrates, once again, why non-professionals shouldn't short-sell stocks. \n</p>\n<p>\n  Take a look at the <a href=\"https://laohu8.com/S/AONE\">one</a>-year chart  for GameStop's stock through Jan. 25: \n</p>\n<p>\n  That's a rocket ride, as investors who connected through Reddit poured money into the shares, pushing the price up,  which forced investors with short positions to cover, which pushed up the shares even higher, despite a lack of any recent good financial news from the company , as Wallace Witkowski explained. \n</p>\n<p>\n  Short-selling is when an investor borrows shares and immediately sells them, hoping he or she can buy them back later at a lower price, return them to the lender and pocket the difference. \n</p>\n<p>\n  What makes shorting stocks best left to professionals is the potential for unlimited losses. In contrast, if you buy shares of a company (take a \"long\" position) and the stock falls, your potential loss is the amount of your investment. It can be wiped out if the company goes bankrupt. \n</p>\n<p>\n  But if you short a stock, what if it goes up and keeps going up? Your loss potential goes to infinity. At some point you will probably give up and \"cover\" your short position by buying the shares to return them to the lender, and take the loss. If you borrow shares and sell them for $10, and then cover at $20, you just lost $10 a share. If a stock you have shorted rises, your broker eventually will demand more collateral -- cash set aside to protect the broker from potential losses as your loss position increases in size. \n</p>\n<p>\n  So a short squeeze is a scramble among investors with short positions to buy shares and cover as quickly as possible. It can create a feeding frenzy and a temporary spike in the share price, as we have seen for GameStop. \n</p>\n<p>\n  On Monday, while discussing GameStop, Jim Cramer said on CNBC  that \"[t]he mechanics of the market are breaking down. It's arguable that these people are all <a href=\"https://laohu8.com/S/AONE.U\">one</a> group.\" \n</p>\n<p>\n  Starting with the S&amp;P Composite 1500 Index (made up of the S&amp;P 500 , the S&amp;P 400 Mid Cap Index <a href=\"https://laohu8.com/S/MID\">$(MID)$</a> and the S&amp;P Small-Cap 600 Index ), here are the 20 stocks with the highest percentages of shares sold short against the total number of shares available for trading: \n</p>\n<p>\n  Scroll the table to see all the data. \n</p>\n<p>\n  The short percentages supplied by FactSet are updated twice a month, based on the most recently available data for shares sold short and the number of shares outstanding and available for trading as of the previous month-end. \n</p>\n<p>\n  Lamensdorf, who co-manages the AdvisorShares <a href=\"https://laohu8.com/S/HDGE\">Ranger Equity Bear ETF</a> (HDGE), argues that any short percentage \"over 30% to 40% is outrageously high.\" Participating in a trade that is so aggressive is very risky because the chance of a short squeeze is so much higher, he said during an interview. \n</p>\n<p>\n  Read:As day traders make wild options bets in search of 'lottery-like payoffs' in the stock market, some fear history is repeating itself  \n</p>\n<p>\n  HDGE is designed to be used by professional investors as a hedging tool. The ETF takes short positions in companies its managers believe exhibit low earnings quality or \"aggressive accounting\" that may \"mask operational deterioration.\" \n</p>\n<p>\n  Lamensdorf stressed that in a bull market, a short-only fund is \"a very lonely place,\" and that it is meant to be used to help investors create their own long/short strategies. \n</p>\n<p>\n  Professional money managers' long/short strategies help explain why a company such as CleanSpark Inc. <a href=\"https://laohu8.com/S/CLSK\">$(CLSK)$</a>, whose shares have risen from about $10 in late November to $25 recently, still has 10% of its shares sold short. \n</p>\n<p>\n  \"Some of the quantitative investors are levered two-to-one, and they are long/short similar companies, and are just trying to play the spread between the two. They do not care if they are squeezed with some, because they have something on the other side appreciating at a similar rate,\" according to Lamensdorf. \n</p>\n<p>\n  While discussing the GameStop short squeeze, Lamensdorf said this sort of action -- individual investors using social media to greatly affect a stock's movement -- isn't happening with large companies. Tesla Inc. (TSLA) provides an astounding example. \n</p>\n<p>\n  When asked how it was possible for more  than 100% of GameStop's shares to be sold short, Lamensdorf said that there are places where people can have \"naked\" short positions -- those that didn't involve actually borrowing the shares to short them. \n</p>\n<p>\n  \"It is illegal, in general, to short a stock without borrowing,\" he said, \"but sometimes a broker is not as careful as it need to be.\" \n</p>\n<p>\n  In the S&amp;P Composite 1500, here are the 20 companies with the highest amount of dollars' worth of shares sold short: \n</p>\n<p>\n  So 8% of Tesla's float is sold short, but that is $66.7 billion. \n</p>\n<p>\n  \"That's not Robinhood, dude!\" Lamensdorf said -- emphasizing that for the largest companies, the short action is controlled by hedge funds and other professional investors. \n</p>\n<p>\n  It is notable that GameStop is on both lists -- it shows how extreme the situation is for that stock, at least until FactSet's data catches up with all the covered short positions. \n</p>\n<p>\n  Take a look at the second company on the second table: Amazon has only 1% of its float sold short, but that adds up to $12.7 billion. Next is Apple with a significant 5% short, for $12.5 billion. Other companies on the list that may surprise you include Microsoft Corp. <a href=\"https://laohu8.com/S/MSFT\">$(MSFT)$</a>, <a href=\"https://laohu8.com/S/FB\">Facebook</a> Inc. (FB) and Nvidia Corp. <a href=\"https://laohu8.com/S/NVDA\">$(NVDA)$</a>, but again, these companies have relatively small percentages of short-sales but large market capitalizations. \n</p>\n<p>\n  Lamensdorf  is CEO of ActiveAlts, through which he and colleagues run  a \"momentum\" strategy that focuses on stocks of heavily shorted companies. \n</p>\n<p>\n  An example of a heavily shorted stock that has been very profitable for Lamensdorf is BlackBerry Ltd. (BB.T). Take a look at the one-year chart: \n</p>\n<p>\n  Shares of BlackBerry began to fly up after the company announced a multiyear deal to provide software for Amazon Web Services . Lamensdorf said that BlackBerry had already been \"a core position of ours,\" because of his confidence that the company, under the leadership of CEO John Chen, would continue to enter new contracts with companies developing technology for autonomous vehicles and otherwise connected vehicles. \n</p>\n<p>\n  BlackBerry always had a reputation for excellent network security. That wasn't enough to save its smartphone business from the iPhone and Android phones, but there is a growing need for what BlackBerry offers. \n</p>\n<p>\n  The action for BlackBerry's stock continues to be heated. The shares flew up 28% on Jan. 25, and on the same day, the company released a statement saying it was \"not awar  to develop autonomous driving technology. \n</p>\n<p>\n  According to FactSet, 7.1% of BlackBerry's shares are still sold short. On a market cap that has now reached $10.1 billion, that's more than $700 million in short bets against the company. \n</p>\n<p>\n  \"You are talking about short-sellers down $1.4 billion,\" Lamensdorf said. \n</p>\n<p>\n  -Philip van Doorn; 415-439-6400; AskNewswires@dowjones.com \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n  January 30, 2021 17:11 ET (22:11 GMT)\n</p>\n<p>\n  Copyright (c) 2021 Dow Jones &amp; Company, Inc.\n</p>\n</font></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>How you could lose everything by short-selling stocks, whether it's betting against GameStop or Tesla</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHow you could lose everything by short-selling stocks, whether it's betting against GameStop or Tesla\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-01-31 06:11</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nMW UPDATE: How you could lose everything by short-selling stocks, whether it's betting against GameStop or Tesla\n</p>\n<p>\n  By Philip van Doorn \n</p>\n<p>\n  GameStop short-sellers are blowing up professional investors' funds. But the story is far different for bets against Tesla and other large-cap stocks. \n</p>\n<p>\n  The wild ride for GameStop Corp.'s stock illustrates the power of social media to force short-sellers -- even professional investors -- to give up on their positions and book heavy losses. But talk of individual investors \"breaking\" the mechanics of the stock market may be premature. \n</p>\n<p>\n  Among the S&amp;P Composite 1500, GameStop is the  most heavily shorted stock as a percentage of shares available for sale, according to  FactSet, which updates the numbers twice a month. The most heavily shorted stock in dollars is Tesla Inc. <a href=\"https://laohu8.com/S/TSLA\">$(TSLA)$</a>. \n</p>\n<p>\n  Tesla and other large companies, including Amazon.com Inc. <a href=\"https://laohu8.com/S/AMZN\">$(AMZN)$</a> and Apple Inc. <a href=\"https://laohu8.com/S/AAPL\">$(AAPL)$</a>, have tens of billions of dollars in short sales against their stocks. Those bets center around hedge funds and other professional investors making much bigger wagers than the ones against GameStop. \n</p>\n<p>\n  \"I have never see anybody rush the capital markets like they did [into GameStop's shares], and it could not have occurred without social media. The public has gotten so much more involved in individual stocks that they are overwhelming the professionals right now, in these small- and mid-cap stocks. Not in Tesla,\" said Brad Lamensdorf, CEO of ActiveAlts in Westport, Conn., who runs long and short investment strategies. \n</p>\n<p>\n  Regardless, GameStop's action illustrates, once again, why non-professionals shouldn't short-sell stocks. \n</p>\n<p>\n  Take a look at the <a href=\"https://laohu8.com/S/AONE\">one</a>-year chart  for GameStop's stock through Jan. 25: \n</p>\n<p>\n  That's a rocket ride, as investors who connected through Reddit poured money into the shares, pushing the price up,  which forced investors with short positions to cover, which pushed up the shares even higher, despite a lack of any recent good financial news from the company , as Wallace Witkowski explained. \n</p>\n<p>\n  Short-selling is when an investor borrows shares and immediately sells them, hoping he or she can buy them back later at a lower price, return them to the lender and pocket the difference. \n</p>\n<p>\n  What makes shorting stocks best left to professionals is the potential for unlimited losses. In contrast, if you buy shares of a company (take a \"long\" position) and the stock falls, your potential loss is the amount of your investment. It can be wiped out if the company goes bankrupt. \n</p>\n<p>\n  But if you short a stock, what if it goes up and keeps going up? Your loss potential goes to infinity. At some point you will probably give up and \"cover\" your short position by buying the shares to return them to the lender, and take the loss. If you borrow shares and sell them for $10, and then cover at $20, you just lost $10 a share. If a stock you have shorted rises, your broker eventually will demand more collateral -- cash set aside to protect the broker from potential losses as your loss position increases in size. \n</p>\n<p>\n  So a short squeeze is a scramble among investors with short positions to buy shares and cover as quickly as possible. It can create a feeding frenzy and a temporary spike in the share price, as we have seen for GameStop. \n</p>\n<p>\n  On Monday, while discussing GameStop, Jim Cramer said on CNBC  that \"[t]he mechanics of the market are breaking down. It's arguable that these people are all <a href=\"https://laohu8.com/S/AONE.U\">one</a> group.\" \n</p>\n<p>\n  Starting with the S&amp;P Composite 1500 Index (made up of the S&amp;P 500 , the S&amp;P 400 Mid Cap Index <a href=\"https://laohu8.com/S/MID\">$(MID)$</a> and the S&amp;P Small-Cap 600 Index ), here are the 20 stocks with the highest percentages of shares sold short against the total number of shares available for trading: \n</p>\n<p>\n  Scroll the table to see all the data. \n</p>\n<p>\n  The short percentages supplied by FactSet are updated twice a month, based on the most recently available data for shares sold short and the number of shares outstanding and available for trading as of the previous month-end. \n</p>\n<p>\n  Lamensdorf, who co-manages the AdvisorShares <a href=\"https://laohu8.com/S/HDGE\">Ranger Equity Bear ETF</a> (HDGE), argues that any short percentage \"over 30% to 40% is outrageously high.\" Participating in a trade that is so aggressive is very risky because the chance of a short squeeze is so much higher, he said during an interview. \n</p>\n<p>\n  Read:As day traders make wild options bets in search of 'lottery-like payoffs' in the stock market, some fear history is repeating itself  \n</p>\n<p>\n  HDGE is designed to be used by professional investors as a hedging tool. The ETF takes short positions in companies its managers believe exhibit low earnings quality or \"aggressive accounting\" that may \"mask operational deterioration.\" \n</p>\n<p>\n  Lamensdorf stressed that in a bull market, a short-only fund is \"a very lonely place,\" and that it is meant to be used to help investors create their own long/short strategies. \n</p>\n<p>\n  Professional money managers' long/short strategies help explain why a company such as CleanSpark Inc. <a href=\"https://laohu8.com/S/CLSK\">$(CLSK)$</a>, whose shares have risen from about $10 in late November to $25 recently, still has 10% of its shares sold short. \n</p>\n<p>\n  \"Some of the quantitative investors are levered two-to-one, and they are long/short similar companies, and are just trying to play the spread between the two. They do not care if they are squeezed with some, because they have something on the other side appreciating at a similar rate,\" according to Lamensdorf. \n</p>\n<p>\n  While discussing the GameStop short squeeze, Lamensdorf said this sort of action -- individual investors using social media to greatly affect a stock's movement -- isn't happening with large companies. Tesla Inc. (TSLA) provides an astounding example. \n</p>\n<p>\n  When asked how it was possible for more  than 100% of GameStop's shares to be sold short, Lamensdorf said that there are places where people can have \"naked\" short positions -- those that didn't involve actually borrowing the shares to short them. \n</p>\n<p>\n  \"It is illegal, in general, to short a stock without borrowing,\" he said, \"but sometimes a broker is not as careful as it need to be.\" \n</p>\n<p>\n  In the S&amp;P Composite 1500, here are the 20 companies with the highest amount of dollars' worth of shares sold short: \n</p>\n<p>\n  So 8% of Tesla's float is sold short, but that is $66.7 billion. \n</p>\n<p>\n  \"That's not Robinhood, dude!\" Lamensdorf said -- emphasizing that for the largest companies, the short action is controlled by hedge funds and other professional investors. \n</p>\n<p>\n  It is notable that GameStop is on both lists -- it shows how extreme the situation is for that stock, at least until FactSet's data catches up with all the covered short positions. \n</p>\n<p>\n  Take a look at the second company on the second table: Amazon has only 1% of its float sold short, but that adds up to $12.7 billion. Next is Apple with a significant 5% short, for $12.5 billion. Other companies on the list that may surprise you include Microsoft Corp. <a href=\"https://laohu8.com/S/MSFT\">$(MSFT)$</a>, <a href=\"https://laohu8.com/S/FB\">Facebook</a> Inc. (FB) and Nvidia Corp. <a href=\"https://laohu8.com/S/NVDA\">$(NVDA)$</a>, but again, these companies have relatively small percentages of short-sales but large market capitalizations. \n</p>\n<p>\n  Lamensdorf  is CEO of ActiveAlts, through which he and colleagues run  a \"momentum\" strategy that focuses on stocks of heavily shorted companies. \n</p>\n<p>\n  An example of a heavily shorted stock that has been very profitable for Lamensdorf is BlackBerry Ltd. (BB.T). Take a look at the one-year chart: \n</p>\n<p>\n  Shares of BlackBerry began to fly up after the company announced a multiyear deal to provide software for Amazon Web Services . Lamensdorf said that BlackBerry had already been \"a core position of ours,\" because of his confidence that the company, under the leadership of CEO John Chen, would continue to enter new contracts with companies developing technology for autonomous vehicles and otherwise connected vehicles. \n</p>\n<p>\n  BlackBerry always had a reputation for excellent network security. That wasn't enough to save its smartphone business from the iPhone and Android phones, but there is a growing need for what BlackBerry offers. \n</p>\n<p>\n  The action for BlackBerry's stock continues to be heated. The shares flew up 28% on Jan. 25, and on the same day, the company released a statement saying it was \"not awar  to develop autonomous driving technology. \n</p>\n<p>\n  According to FactSet, 7.1% of BlackBerry's shares are still sold short. On a market cap that has now reached $10.1 billion, that's more than $700 million in short bets against the company. \n</p>\n<p>\n  \"You are talking about short-sellers down $1.4 billion,\" Lamensdorf said. \n</p>\n<p>\n  -Philip van Doorn; 415-439-6400; AskNewswires@dowjones.com \n</p>\n<pre>\n \n</pre>\n<p>\n  <a href=\"https://laohu8.com/S/END\">$(END)$</a> Dow Jones Newswires\n</p>\n<p>\n  January 30, 2021 17:11 ET (22:11 GMT)\n</p>\n<p>\n  Copyright (c) 2021 Dow Jones &amp; Company, Inc.\n</p>\n</font></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉","AMZN":"亚马逊","BB":"黑莓","GME":"游戏驿站","AAPL":"苹果"},"source_url":"http://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2107223679","content_text":"MW UPDATE: How you could lose everything by short-selling stocks, whether it's betting against GameStop or Tesla\n\n\n  By Philip van Doorn \n\n\n  GameStop short-sellers are blowing up professional investors' funds. But the story is far different for bets against Tesla and other large-cap stocks. \n\n\n  The wild ride for GameStop Corp.'s stock illustrates the power of social media to force short-sellers -- even professional investors -- to give up on their positions and book heavy losses. But talk of individual investors \"breaking\" the mechanics of the stock market may be premature. \n\n\n  Among the S&P Composite 1500, GameStop is the  most heavily shorted stock as a percentage of shares available for sale, according to  FactSet, which updates the numbers twice a month. The most heavily shorted stock in dollars is Tesla Inc. $(TSLA)$. \n\n\n  Tesla and other large companies, including Amazon.com Inc. $(AMZN)$ and Apple Inc. $(AAPL)$, have tens of billions of dollars in short sales against their stocks. Those bets center around hedge funds and other professional investors making much bigger wagers than the ones against GameStop. \n\n\n  \"I have never see anybody rush the capital markets like they did [into GameStop's shares], and it could not have occurred without social media. The public has gotten so much more involved in individual stocks that they are overwhelming the professionals right now, in these small- and mid-cap stocks. Not in Tesla,\" said Brad Lamensdorf, CEO of ActiveAlts in Westport, Conn., who runs long and short investment strategies. \n\n\n  Regardless, GameStop's action illustrates, once again, why non-professionals shouldn't short-sell stocks. \n\n\n  Take a look at the one-year chart  for GameStop's stock through Jan. 25: \n\n\n  That's a rocket ride, as investors who connected through Reddit poured money into the shares, pushing the price up,  which forced investors with short positions to cover, which pushed up the shares even higher, despite a lack of any recent good financial news from the company , as Wallace Witkowski explained. \n\n\n  Short-selling is when an investor borrows shares and immediately sells them, hoping he or she can buy them back later at a lower price, return them to the lender and pocket the difference. \n\n\n  What makes shorting stocks best left to professionals is the potential for unlimited losses. In contrast, if you buy shares of a company (take a \"long\" position) and the stock falls, your potential loss is the amount of your investment. It can be wiped out if the company goes bankrupt. \n\n\n  But if you short a stock, what if it goes up and keeps going up? Your loss potential goes to infinity. At some point you will probably give up and \"cover\" your short position by buying the shares to return them to the lender, and take the loss. If you borrow shares and sell them for $10, and then cover at $20, you just lost $10 a share. If a stock you have shorted rises, your broker eventually will demand more collateral -- cash set aside to protect the broker from potential losses as your loss position increases in size. \n\n\n  So a short squeeze is a scramble among investors with short positions to buy shares and cover as quickly as possible. It can create a feeding frenzy and a temporary spike in the share price, as we have seen for GameStop. \n\n\n  On Monday, while discussing GameStop, Jim Cramer said on CNBC  that \"[t]he mechanics of the market are breaking down. It's arguable that these people are all one group.\" \n\n\n  Starting with the S&P Composite 1500 Index (made up of the S&P 500 , the S&P 400 Mid Cap Index $(MID)$ and the S&P Small-Cap 600 Index ), here are the 20 stocks with the highest percentages of shares sold short against the total number of shares available for trading: \n\n\n  Scroll the table to see all the data. \n\n\n  The short percentages supplied by FactSet are updated twice a month, based on the most recently available data for shares sold short and the number of shares outstanding and available for trading as of the previous month-end. \n\n\n  Lamensdorf, who co-manages the AdvisorShares Ranger Equity Bear ETF (HDGE), argues that any short percentage \"over 30% to 40% is outrageously high.\" Participating in a trade that is so aggressive is very risky because the chance of a short squeeze is so much higher, he said during an interview. \n\n\n  Read:As day traders make wild options bets in search of 'lottery-like payoffs' in the stock market, some fear history is repeating itself  \n\n\n  HDGE is designed to be used by professional investors as a hedging tool. The ETF takes short positions in companies its managers believe exhibit low earnings quality or \"aggressive accounting\" that may \"mask operational deterioration.\" \n\n\n  Lamensdorf stressed that in a bull market, a short-only fund is \"a very lonely place,\" and that it is meant to be used to help investors create their own long/short strategies. \n\n\n  Professional money managers' long/short strategies help explain why a company such as CleanSpark Inc. $(CLSK)$, whose shares have risen from about $10 in late November to $25 recently, still has 10% of its shares sold short. \n\n\n  \"Some of the quantitative investors are levered two-to-one, and they are long/short similar companies, and are just trying to play the spread between the two. They do not care if they are squeezed with some, because they have something on the other side appreciating at a similar rate,\" according to Lamensdorf. \n\n\n  While discussing the GameStop short squeeze, Lamensdorf said this sort of action -- individual investors using social media to greatly affect a stock's movement -- isn't happening with large companies. Tesla Inc. (TSLA) provides an astounding example. \n\n\n  When asked how it was possible for more  than 100% of GameStop's shares to be sold short, Lamensdorf said that there are places where people can have \"naked\" short positions -- those that didn't involve actually borrowing the shares to short them. \n\n\n  \"It is illegal, in general, to short a stock without borrowing,\" he said, \"but sometimes a broker is not as careful as it need to be.\" \n\n\n  In the S&P Composite 1500, here are the 20 companies with the highest amount of dollars' worth of shares sold short: \n\n\n  So 8% of Tesla's float is sold short, but that is $66.7 billion. \n\n\n  \"That's not Robinhood, dude!\" Lamensdorf said -- emphasizing that for the largest companies, the short action is controlled by hedge funds and other professional investors. \n\n\n  It is notable that GameStop is on both lists -- it shows how extreme the situation is for that stock, at least until FactSet's data catches up with all the covered short positions. \n\n\n  Take a look at the second company on the second table: Amazon has only 1% of its float sold short, but that adds up to $12.7 billion. Next is Apple with a significant 5% short, for $12.5 billion. Other companies on the list that may surprise you include Microsoft Corp. $(MSFT)$, Facebook Inc. (FB) and Nvidia Corp. $(NVDA)$, but again, these companies have relatively small percentages of short-sales but large market capitalizations. \n\n\n  Lamensdorf  is CEO of ActiveAlts, through which he and colleagues run  a \"momentum\" strategy that focuses on stocks of heavily shorted companies. \n\n\n  An example of a heavily shorted stock that has been very profitable for Lamensdorf is BlackBerry Ltd. (BB.T). Take a look at the one-year chart: \n\n\n  Shares of BlackBerry began to fly up after the company announced a multiyear deal to provide software for Amazon Web Services . Lamensdorf said that BlackBerry had already been \"a core position of ours,\" because of his confidence that the company, under the leadership of CEO John Chen, would continue to enter new contracts with companies developing technology for autonomous vehicles and otherwise connected vehicles. \n\n\n  BlackBerry always had a reputation for excellent network security. That wasn't enough to save its smartphone business from the iPhone and Android phones, but there is a growing need for what BlackBerry offers. \n\n\n  The action for BlackBerry's stock continues to be heated. The shares flew up 28% on Jan. 25, and on the same day, the company released a statement saying it was \"not awar  to develop autonomous driving technology. \n\n\n  According to FactSet, 7.1% of BlackBerry's shares are still sold short. On a market cap that has now reached $10.1 billion, that's more than $700 million in short bets against the company. \n\n\n  \"You are talking about short-sellers down $1.4 billion,\" Lamensdorf said. \n\n\n  -Philip van Doorn; 415-439-6400; AskNewswires@dowjones.com \n\n\n \n\n\n$(END)$ Dow Jones Newswires\n\n\n  January 30, 2021 17:11 ET (22:11 GMT)\n\n\n  Copyright (c) 2021 Dow Jones & Company, Inc.","news_type":1},"isVote":1,"tweetType":1,"viewCount":195,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":386076859,"gmtCreate":1613121547571,"gmtModify":1704878578795,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567658644109643","idStr":"3567658644109643"},"themes":[],"htmlText":"Up up up","listText":"Up up up","text":"Up up up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/386076859","repostId":"2110026963","repostType":2,"repost":{"id":"2110026963","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1613109422,"share":"https://ttm.financial/m/news/2110026963?lang=&edition=fundamental","pubTime":"2021-02-12 13:57","market":"us","language":"en","title":"Here's the formula for spotting genuinely undervalued companies, claims this investment house","url":"https://stock-news.laohu8.com/highlight/detail?id=2110026963","media":"Dow Jones","summary":"The growth stock vs. value stock dichotomy doesn't make sense, says ValuAnalysis. For most of 2020, investors poured money into names like online retailer Amazon $$, electric-car maker Tesla $$, and e-commerce platform Shopify -- \"growth\" stocks that kept indexes afloat in a turbulent year that hammered share prices across the board.But when news broke in early November 2020 that drug company Pfizer $$ and its partner BioNTech $$ had developed an effective vaccine against COVID-19, something pro","content":"<p>MW Here's the formula for spotting genuinely undervalued companies, claims this investment house</p>\n<p>The growth stock vs. value stock dichotomy doesn't make sense, says ValuAnalysis</p>\n<p>For most of 2020, investors poured money into names like online retailer Amazon <a href=\"https://laohu8.com/S/AMZN\">$(AMZN)$</a>, electric-car maker Tesla <a href=\"https://laohu8.com/S/TSLA\">$(TSLA)$</a>, and e-commerce platform Shopify (SHOP.T)-- \"growth\" stocks that kept indexes afloat in a turbulent year that hammered share prices across the board.</p>\n<p>But when news broke in early November 2020 that drug company Pfizer <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> and its partner BioNTech <a href=\"https://laohu8.com/S/BNTX\">$(BNTX)$</a> had developed an effective vaccine against COVID-19, something profound happened in financial markets.</p>\n<p>Investors rotated out of these investments in favor of \"value\" stocks hammered by the COVID-19 pandemic, like airlines.</p>\n<p>This rotation was based on an essential concept in investing: There are some stocks that are clearly undervalued based on standard metrics.</p>\n<p>And it is completely flawed, according to research from ValuAnalysis, a London-based fund manager and equity investment boutique, which specializes in valuation.</p>\n<p>The apparent difference between growth stocks and value stocks is that the former is overvalued based on fundamental metrics while the latter is undervalued.</p>\n<p>\"Everyone knows that this thing doesn't make any sense because growth is not the opposite of value,\" Pascal Costantini, who led the research at ValuAnalysis, tells MarketWatch.</p>\n<p>\"It should be high-growth and low-growth, and I can imagine that, somewhere in an office, some guy said 'well this is not catchy enough, so how about growth and value?'\"</p>\n<p>Analysts and investors use metrics like the price-to-earnings ratio, or price multiple, to value stocks. ValuAnalysis uses price as a multiple of normalized net free cash flow as its benchmark, and identifies the imaginary dividing line between value and growth stocks at 35x, which is the market median.</p>\n<p>The value vs. growth divide would suggest that a company trading at a 17x earnings multiple is undervalued. In reality, ValuAnalysis says it is likely a company that won't grow.</p>\n<p>In reality, a stock's value is based on the company's ability to grow free cash flow in an environment where the cost of capital is 5% to 6%. So if a company isn't outpacing that by improving revenue and margins, the multiple won't increase and the stock price is unlikely to rise.</p>\n<p>Stocks that are actually undervalued will trade between 25x and 35x free cash flow, Costantini says, outpacing the cost of capital but not breaking past the market median.</p>\n<p>To have potential, a company's accumulation of assets or revenue growth must outpace increases in global gross domestic product, and ideally show signs of accelerating. There must also be an increase in operational leverage through revenue or margins. A decrease in the risk premium, such as through advances in controlling carbon emissions, helps.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here's the formula for spotting genuinely undervalued companies, claims this investment house</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere's the formula for spotting genuinely undervalued companies, claims this investment house\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-02-12 13:57</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>MW Here's the formula for spotting genuinely undervalued companies, claims this investment house</p>\n<p>The growth stock vs. value stock dichotomy doesn't make sense, says ValuAnalysis</p>\n<p>For most of 2020, investors poured money into names like online retailer Amazon <a href=\"https://laohu8.com/S/AMZN\">$(AMZN)$</a>, electric-car maker Tesla <a href=\"https://laohu8.com/S/TSLA\">$(TSLA)$</a>, and e-commerce platform Shopify (SHOP.T)-- \"growth\" stocks that kept indexes afloat in a turbulent year that hammered share prices across the board.</p>\n<p>But when news broke in early November 2020 that drug company Pfizer <a href=\"https://laohu8.com/S/PFE\">$(PFE)$</a> and its partner BioNTech <a href=\"https://laohu8.com/S/BNTX\">$(BNTX)$</a> had developed an effective vaccine against COVID-19, something profound happened in financial markets.</p>\n<p>Investors rotated out of these investments in favor of \"value\" stocks hammered by the COVID-19 pandemic, like airlines.</p>\n<p>This rotation was based on an essential concept in investing: There are some stocks that are clearly undervalued based on standard metrics.</p>\n<p>And it is completely flawed, according to research from ValuAnalysis, a London-based fund manager and equity investment boutique, which specializes in valuation.</p>\n<p>The apparent difference between growth stocks and value stocks is that the former is overvalued based on fundamental metrics while the latter is undervalued.</p>\n<p>\"Everyone knows that this thing doesn't make any sense because growth is not the opposite of value,\" Pascal Costantini, who led the research at ValuAnalysis, tells MarketWatch.</p>\n<p>\"It should be high-growth and low-growth, and I can imagine that, somewhere in an office, some guy said 'well this is not catchy enough, so how about growth and value?'\"</p>\n<p>Analysts and investors use metrics like the price-to-earnings ratio, or price multiple, to value stocks. ValuAnalysis uses price as a multiple of normalized net free cash flow as its benchmark, and identifies the imaginary dividing line between value and growth stocks at 35x, which is the market median.</p>\n<p>The value vs. growth divide would suggest that a company trading at a 17x earnings multiple is undervalued. In reality, ValuAnalysis says it is likely a company that won't grow.</p>\n<p>In reality, a stock's value is based on the company's ability to grow free cash flow in an environment where the cost of capital is 5% to 6%. So if a company isn't outpacing that by improving revenue and margins, the multiple won't increase and the stock price is unlikely to rise.</p>\n<p>Stocks that are actually undervalued will trade between 25x and 35x free cash flow, Costantini says, outpacing the cost of capital but not breaking past the market median.</p>\n<p>To have potential, a company's accumulation of assets or revenue growth must outpace increases in global gross domestic product, and ideally show signs of accelerating. There must also be an increase in operational leverage through revenue or margins. A decrease in the risk premium, such as through advances in controlling carbon emissions, helps.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/15e20574f8fb568333181d61bb200086","relate_stocks":{"TSLA":"特斯拉","AMZN":"亚马逊","PFE":"辉瑞"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2110026963","content_text":"MW Here's the formula for spotting genuinely undervalued companies, claims this investment house\nThe growth stock vs. value stock dichotomy doesn't make sense, says ValuAnalysis\nFor most of 2020, investors poured money into names like online retailer Amazon $(AMZN)$, electric-car maker Tesla $(TSLA)$, and e-commerce platform Shopify (SHOP.T)-- \"growth\" stocks that kept indexes afloat in a turbulent year that hammered share prices across the board.\nBut when news broke in early November 2020 that drug company Pfizer $(PFE)$ and its partner BioNTech $(BNTX)$ had developed an effective vaccine against COVID-19, something profound happened in financial markets.\nInvestors rotated out of these investments in favor of \"value\" stocks hammered by the COVID-19 pandemic, like airlines.\nThis rotation was based on an essential concept in investing: There are some stocks that are clearly undervalued based on standard metrics.\nAnd it is completely flawed, according to research from ValuAnalysis, a London-based fund manager and equity investment boutique, which specializes in valuation.\nThe apparent difference between growth stocks and value stocks is that the former is overvalued based on fundamental metrics while the latter is undervalued.\n\"Everyone knows that this thing doesn't make any sense because growth is not the opposite of value,\" Pascal Costantini, who led the research at ValuAnalysis, tells MarketWatch.\n\"It should be high-growth and low-growth, and I can imagine that, somewhere in an office, some guy said 'well this is not catchy enough, so how about growth and value?'\"\nAnalysts and investors use metrics like the price-to-earnings ratio, or price multiple, to value stocks. ValuAnalysis uses price as a multiple of normalized net free cash flow as its benchmark, and identifies the imaginary dividing line between value and growth stocks at 35x, which is the market median.\nThe value vs. growth divide would suggest that a company trading at a 17x earnings multiple is undervalued. In reality, ValuAnalysis says it is likely a company that won't grow.\nIn reality, a stock's value is based on the company's ability to grow free cash flow in an environment where the cost of capital is 5% to 6%. So if a company isn't outpacing that by improving revenue and margins, the multiple won't increase and the stock price is unlikely to rise.\nStocks that are actually undervalued will trade between 25x and 35x free cash flow, Costantini says, outpacing the cost of capital but not breaking past the market median.\nTo have potential, a company's accumulation of assets or revenue growth must outpace increases in global gross domestic product, and ideally show signs of accelerating. There must also be an increase in operational leverage through revenue or margins. A decrease in the risk premium, such as through advances in controlling carbon emissions, helps.","news_type":1},"isVote":1,"tweetType":1,"viewCount":368,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":317022586,"gmtCreate":1612400076245,"gmtModify":1704870637343,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567658644109643","idStr":"3567658644109643"},"themes":[],"htmlText":"Another big player","listText":"Another big player","text":"Another big player","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/317022586","repostId":"2108795093","repostType":2,"isVote":1,"tweetType":1,"viewCount":810,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":386469204,"gmtCreate":1613258317708,"gmtModify":1704879570319,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567658644109643","idStr":"3567658644109643"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/386469204","repostId":"2111807728","repostType":2,"isVote":1,"tweetType":1,"viewCount":346,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":386631333,"gmtCreate":1613168819622,"gmtModify":1704879132334,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567658644109643","idStr":"3567658644109643"},"themes":[],"htmlText":"Wow","listText":"Wow","text":"Wow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/386631333","repostId":"2111071977","repostType":2,"repost":{"id":"2111071977","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1613166338,"share":"https://ttm.financial/m/news/2111071977?lang=&edition=fundamental","pubTime":"2021-02-13 05:45","market":"us","language":"en","title":"UPDATE 1-Ex-'Mandalorian' actress Gina Carano to make film with conservative outlet","url":"https://stock-news.laohu8.com/highlight/detail?id=2111071977","media":"Reuters","summary":"(Adds details on Carano's role, Mandalorian spinoff)   By Lisa Richwine   LOS ANGELES, Feb 12 (Reute","content":"<html><body><p>(Adds details on Carano's role, Mandalorian spinoff)</p><p>   By Lisa Richwine</p><p>   LOS ANGELES, Feb 12 (Reuters) - Gina Carano, the \"Mandalorian\" actress who was dropped from the \"Star Wars\" spinoff over what the studio called \"abhorrent and unacceptable\" social media posts, said on Friday she will make a film with conservative company The Daily Wire.</p><p>   Walt Disney Co's    Lucasfilm studio said on Wednesday it would no longer work with her after she posted on Instagram drawing parallels between persecution of Jews in Nazi Germany and the treatment of people who hold conservative political views today.   </p><p>   The Daily Wire said Carano will produce and star in an upcoming film exclusively for subscribers to its website, which was co-founded by conservative political commentator Ben Shapiro. </p><p>   In a statement on the site, Carano said she was sending a message of hope to everyone living in fear of cancellation by what she called \"the totalitarian mob.\" </p><p>   \"I have only just begun using my voice which is now freer than ever before ... They can't cancel us if we don't let them.\"</p><p>   In \"The Mandalorian,\" Carano played Cara Dune, a warrior who had become a marshal in the New Republic.</p><p>   Lucasfilm said on Wednesday it had no plans to work with Carano in the future. The company had announced in December that a \"Mandalorian\" spinoff called \"Rangers of the New Republic\" was in development, and Hollywood trade publications had speculated that Carano would play a role in that series. </p><p>   The actress had also come under fire in November for posts on <a href=\"https://laohu8.com/S/TWTR\">Twitter</a> in which she derided mask-wearing amid the COVID-19 pandemic, and for promoting baseless claims of voter fraud after the U.S. presidential election.     </p><p>   Shapiro said The Daily Wire aimed to \"provide an alternative not just for consumers, but for creators who refuse to bow to the mob.\" </p><p>   \"We're just as eager to show Hollywood that if they want to keep cancelling those who think differently, they'll just be helping us build the X-wing to take down their Death Star,\" he said in a statement on the Daily Wire website.    </p><p> (Reporting by Lisa Richwine; Editing by Daniel Wallis)</p><p>((lisa.richwine@thomsonreuters.com; Follow me on Twitter @LARichwine; 1-424-434-7324; Reuters Messaging: lisa.richwine.thomsonreuters.com@reuters.net))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>UPDATE 1-Ex-'Mandalorian' actress Gina Carano to make film with conservative outlet</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUPDATE 1-Ex-'Mandalorian' actress Gina Carano to make film with conservative outlet\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-13 05:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>(Adds details on Carano's role, Mandalorian spinoff)</p><p>   By Lisa Richwine</p><p>   LOS ANGELES, Feb 12 (Reuters) - Gina Carano, the \"Mandalorian\" actress who was dropped from the \"Star Wars\" spinoff over what the studio called \"abhorrent and unacceptable\" social media posts, said on Friday she will make a film with conservative company The Daily Wire.</p><p>   Walt Disney Co's    Lucasfilm studio said on Wednesday it would no longer work with her after she posted on Instagram drawing parallels between persecution of Jews in Nazi Germany and the treatment of people who hold conservative political views today.   </p><p>   The Daily Wire said Carano will produce and star in an upcoming film exclusively for subscribers to its website, which was co-founded by conservative political commentator Ben Shapiro. </p><p>   In a statement on the site, Carano said she was sending a message of hope to everyone living in fear of cancellation by what she called \"the totalitarian mob.\" </p><p>   \"I have only just begun using my voice which is now freer than ever before ... They can't cancel us if we don't let them.\"</p><p>   In \"The Mandalorian,\" Carano played Cara Dune, a warrior who had become a marshal in the New Republic.</p><p>   Lucasfilm said on Wednesday it had no plans to work with Carano in the future. The company had announced in December that a \"Mandalorian\" spinoff called \"Rangers of the New Republic\" was in development, and Hollywood trade publications had speculated that Carano would play a role in that series. </p><p>   The actress had also come under fire in November for posts on <a href=\"https://laohu8.com/S/TWTR\">Twitter</a> in which she derided mask-wearing amid the COVID-19 pandemic, and for promoting baseless claims of voter fraud after the U.S. presidential election.     </p><p>   Shapiro said The Daily Wire aimed to \"provide an alternative not just for consumers, but for creators who refuse to bow to the mob.\" </p><p>   \"We're just as eager to show Hollywood that if they want to keep cancelling those who think differently, they'll just be helping us build the X-wing to take down their Death Star,\" he said in a statement on the Daily Wire website.    </p><p> (Reporting by Lisa Richwine; Editing by Daniel Wallis)</p><p>((lisa.richwine@thomsonreuters.com; Follow me on Twitter @LARichwine; 1-424-434-7324; Reuters Messaging: lisa.richwine.thomsonreuters.com@reuters.net))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DIS":"迪士尼"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2111071977","content_text":"(Adds details on Carano's role, Mandalorian spinoff)   By Lisa Richwine   LOS ANGELES, Feb 12 (Reuters) - Gina Carano, the \"Mandalorian\" actress who was dropped from the \"Star Wars\" spinoff over what the studio called \"abhorrent and unacceptable\" social media posts, said on Friday she will make a film with conservative company The Daily Wire.   Walt Disney Co's    Lucasfilm studio said on Wednesday it would no longer work with her after she posted on Instagram drawing parallels between persecution of Jews in Nazi Germany and the treatment of people who hold conservative political views today.      The Daily Wire said Carano will produce and star in an upcoming film exclusively for subscribers to its website, which was co-founded by conservative political commentator Ben Shapiro.    In a statement on the site, Carano said she was sending a message of hope to everyone living in fear of cancellation by what she called \"the totalitarian mob.\"    \"I have only just begun using my voice which is now freer than ever before ... They can't cancel us if we don't let them.\"   In \"The Mandalorian,\" Carano played Cara Dune, a warrior who had become a marshal in the New Republic.   Lucasfilm said on Wednesday it had no plans to work with Carano in the future. The company had announced in December that a \"Mandalorian\" spinoff called \"Rangers of the New Republic\" was in development, and Hollywood trade publications had speculated that Carano would play a role in that series.    The actress had also come under fire in November for posts on Twitter in which she derided mask-wearing amid the COVID-19 pandemic, and for promoting baseless claims of voter fraud after the U.S. presidential election.        Shapiro said The Daily Wire aimed to \"provide an alternative not just for consumers, but for creators who refuse to bow to the mob.\"    \"We're just as eager to show Hollywood that if they want to keep cancelling those who think differently, they'll just be helping us build the X-wing to take down their Death Star,\" he said in a statement on the Daily Wire website.     (Reporting by Lisa Richwine; Editing by Daniel Wallis)((lisa.richwine@thomsonreuters.com; Follow me on Twitter @LARichwine; 1-424-434-7324; Reuters Messaging: lisa.richwine.thomsonreuters.com@reuters.net))","news_type":1},"isVote":1,"tweetType":1,"viewCount":402,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":389370655,"gmtCreate":1612702142177,"gmtModify":1704873577895,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567658644109643","idStr":"3567658644109643"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/389370655","repostId":"2109704729","repostType":2,"isVote":1,"tweetType":1,"viewCount":526,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":317022073,"gmtCreate":1612400045493,"gmtModify":1704870636210,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567658644109643","idStr":"3567658644109643"},"themes":[],"htmlText":"Up","listText":"Up","text":"Up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/317022073","repostId":"2108579668","repostType":2,"repost":{"id":"2108579668","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1612396458,"share":"https://ttm.financial/m/news/2108579668?lang=&edition=fundamental","pubTime":"2021-02-04 07:54","market":"us","language":"en","title":"UPDATE 1-Social network Parler terminates CEO John Matze","url":"https://stock-news.laohu8.com/highlight/detail?id=2108579668","media":"Reuters","summary":"(Adds quote and context)   Feb 3 (Reuters) - Parler, a social media platform favored by U.S conserva","content":"<html><body><p>(Adds quote and context)</p><p>   Feb 3 (Reuters) - Parler, a social media platform favored by U.S conservatives, has dismissed CEO John Matze, according to Matze on Wednesday, as the site has largely gone  offline after the Jan. 6 attack on the U.S. Capitol. </p><p>   Matze confirmed the move in a text message to Reuters.</p><p>   \"On January 29, 2021, the Parler board controlled by Rebekah Mercer decided to immediately terminate my position as CEO of Parler. I did not participate in this decision,\" Matze said in a memo sent to Parler staff, originally reported by Fox News.</p><p>   The company did not immediately respond to a request for comment.</p><p>   Parler remains largely offline after being dropped by Seattle-based Amazon's    cloud-hosting division and the app stores of Apple Inc    and Alphabet Inc's    Google following the Jan. 6 siege of the U.S. Capitol.</p><p>   Parler, which was founded in 2018, has styled itself as a \"free speech-driven\" space. The app has largely attracted U.S. conservatives who disagree with rules around content on social media sites like <a href=\"https://laohu8.com/S/FB\">Facebook</a> Inc     and <a href=\"https://laohu8.com/S/TWTR\">Twitter</a> Inc   .</p><p> (Reporting by Kanishka Singh in Bengaluru, Elizabeth Culliford in New York and Katie Paul in Palo Alto Editing by Chris Reese and Cynthia Osterman)</p><p>((Kanishka.Singh@thomsonreuters.com; +91 8061822801;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>UPDATE 1-Social network Parler terminates CEO John Matze</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUPDATE 1-Social network Parler terminates CEO John Matze\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-04 07:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>(Adds quote and context)</p><p>   Feb 3 (Reuters) - Parler, a social media platform favored by U.S conservatives, has dismissed CEO John Matze, according to Matze on Wednesday, as the site has largely gone  offline after the Jan. 6 attack on the U.S. Capitol. </p><p>   Matze confirmed the move in a text message to Reuters.</p><p>   \"On January 29, 2021, the Parler board controlled by Rebekah Mercer decided to immediately terminate my position as CEO of Parler. I did not participate in this decision,\" Matze said in a memo sent to Parler staff, originally reported by Fox News.</p><p>   The company did not immediately respond to a request for comment.</p><p>   Parler remains largely offline after being dropped by Seattle-based Amazon's    cloud-hosting division and the app stores of Apple Inc    and Alphabet Inc's    Google following the Jan. 6 siege of the U.S. Capitol.</p><p>   Parler, which was founded in 2018, has styled itself as a \"free speech-driven\" space. The app has largely attracted U.S. conservatives who disagree with rules around content on social media sites like <a href=\"https://laohu8.com/S/FB\">Facebook</a> Inc     and <a href=\"https://laohu8.com/S/TWTR\">Twitter</a> Inc   .</p><p> (Reporting by Kanishka Singh in Bengaluru, Elizabeth Culliford in New York and Katie Paul in Palo Alto Editing by Chris Reese and Cynthia Osterman)</p><p>((Kanishka.Singh@thomsonreuters.com; +91 8061822801;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"09086":"华夏纳指-U","03086":"华夏纳指","AMZN":"亚马逊","QNETCN":"纳斯达克中美互联网老虎指数"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2108579668","content_text":"(Adds quote and context)   Feb 3 (Reuters) - Parler, a social media platform favored by U.S conservatives, has dismissed CEO John Matze, according to Matze on Wednesday, as the site has largely gone  offline after the Jan. 6 attack on the U.S. Capitol.    Matze confirmed the move in a text message to Reuters.   \"On January 29, 2021, the Parler board controlled by Rebekah Mercer decided to immediately terminate my position as CEO of Parler. I did not participate in this decision,\" Matze said in a memo sent to Parler staff, originally reported by Fox News.   The company did not immediately respond to a request for comment.   Parler remains largely offline after being dropped by Seattle-based Amazon's    cloud-hosting division and the app stores of Apple Inc    and Alphabet Inc's    Google following the Jan. 6 siege of the U.S. Capitol.   Parler, which was founded in 2018, has styled itself as a \"free speech-driven\" space. The app has largely attracted U.S. conservatives who disagree with rules around content on social media sites like Facebook Inc     and Twitter Inc   . (Reporting by Kanishka Singh in Bengaluru, Elizabeth Culliford in New York and Katie Paul in Palo Alto Editing by Chris Reese and Cynthia Osterman)((Kanishka.Singh@thomsonreuters.com; +91 8061822801;))","news_type":1},"isVote":1,"tweetType":1,"viewCount":498,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":314102811,"gmtCreate":1612316052533,"gmtModify":1704869629957,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567658644109643","idStr":"3567658644109643"},"themes":[],"htmlText":"Nice&nbsp;","listText":"Nice&nbsp;","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/314102811","repostId":"2108275853","repostType":2,"repost":{"id":"2108275853","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1612313204,"share":"https://ttm.financial/m/news/2108275853?lang=&edition=fundamental","pubTime":"2021-02-03 08:46","market":"us","language":"en","title":"PRESS DIGEST- Financial Times - Feb. 3","url":"https://stock-news.laohu8.com/highlight/detail?id=2108275853","media":"Reuters","summary":"Feb 3 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified","content":"<html><body><p>Feb 3 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.</p><p>   Headlines</p><p>   UK starts process to form post-Brexit state-aid watchdog </p><p>   Amazon's Jeff Bezos to step aside as chief executive this year </p><p>   Oxford/AstraZeneca study supports UK decision to delay second doses </p><p>   Steve Cohen's Point72 raises $1.5bn </p><p>   Overview</p><p>   Britain will take an important step towards the creation of an independent authority to oversee its post-Brexit subsidy regime on Wednesday when it launches a consultation on how the new body will operate and whether it should have enforcement powers.</p><p>   Amazon.com Inc    said on Tuesday chief executive Jeff Bezos will step aside later this year to become executive chairman, making way for cloud computing division head Andy Jassy to replace him in the role.</p><p>   A single dose of the Oxford and AstraZeneca coronavirus vaccine is 76% effective from three weeks to 12 weeks after the injection, according to an analysis of trial data.</p><p>    Billionaire investor Steven Cohen's Point72 Asset Management has raised $1.5 billion from investors, boosting the hedge fund's assets under management after it lost 10% in January and provided emergency financing to Melvin Capital, the firm at the centre of the GameStop    short squeeze.</p><p> (Compiled by Bengaluru newsroom)</p><p>((globalnewsmonitoring@thomsonreuters.com))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>PRESS DIGEST- Financial Times - Feb. 3</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPRESS DIGEST- Financial Times - Feb. 3\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-03 08:46</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>Feb 3 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.</p><p>   Headlines</p><p>   UK starts process to form post-Brexit state-aid watchdog </p><p>   Amazon's Jeff Bezos to step aside as chief executive this year </p><p>   Oxford/AstraZeneca study supports UK decision to delay second doses </p><p>   Steve Cohen's Point72 raises $1.5bn </p><p>   Overview</p><p>   Britain will take an important step towards the creation of an independent authority to oversee its post-Brexit subsidy regime on Wednesday when it launches a consultation on how the new body will operate and whether it should have enforcement powers.</p><p>   Amazon.com Inc    said on Tuesday chief executive Jeff Bezos will step aside later this year to become executive chairman, making way for cloud computing division head Andy Jassy to replace him in the role.</p><p>   A single dose of the Oxford and AstraZeneca coronavirus vaccine is 76% effective from three weeks to 12 weeks after the injection, according to an analysis of trial data.</p><p>    Billionaire investor Steven Cohen's Point72 Asset Management has raised $1.5 billion from investors, boosting the hedge fund's assets under management after it lost 10% in January and provided emergency financing to Melvin Capital, the firm at the centre of the GameStop    short squeeze.</p><p> (Compiled by Bengaluru newsroom)</p><p>((globalnewsmonitoring@thomsonreuters.com))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"09086":"华夏纳指-U","QNETCN":"纳斯达克中美互联网老虎指数","03086":"华夏纳指","AMZN":"亚马逊"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2108275853","content_text":"Feb 3 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.   Headlines   UK starts process to form post-Brexit state-aid watchdog    Amazon's Jeff Bezos to step aside as chief executive this year    Oxford/AstraZeneca study supports UK decision to delay second doses    Steve Cohen's Point72 raises $1.5bn    Overview   Britain will take an important step towards the creation of an independent authority to oversee its post-Brexit subsidy regime on Wednesday when it launches a consultation on how the new body will operate and whether it should have enforcement powers.   Amazon.com Inc    said on Tuesday chief executive Jeff Bezos will step aside later this year to become executive chairman, making way for cloud computing division head Andy Jassy to replace him in the role.   A single dose of the Oxford and AstraZeneca coronavirus vaccine is 76% effective from three weeks to 12 weeks after the injection, according to an analysis of trial data.    Billionaire investor Steven Cohen's Point72 Asset Management has raised $1.5 billion from investors, boosting the hedge fund's assets under management after it lost 10% in January and provided emergency financing to Melvin Capital, the firm at the centre of the GameStop    short squeeze. (Compiled by Bengaluru newsroom)((globalnewsmonitoring@thomsonreuters.com))","news_type":1},"isVote":1,"tweetType":1,"viewCount":143,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":389370214,"gmtCreate":1612702161938,"gmtModify":1704873577730,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567658644109643","idStr":"3567658644109643"},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/389370214","repostId":"2109704729","repostType":2,"repost":{"id":"2109704729","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1612696631,"share":"https://ttm.financial/m/news/2109704729?lang=&edition=fundamental","pubTime":"2021-02-07 19:17","market":"us","language":"en","title":"REUTERS NEWS SCHEDULE AT 11 a.m. GMT/6 a.m. ET","url":"https://stock-news.laohu8.com/highlight/detail?id=2109704729","media":"Reuters","summary":"Here are the top stories and upcoming coverage plans for Reuters text service as of 11 a.m. GMT/6 a.","content":"<html><body><p>Here are the top stories and upcoming coverage plans for Reuters text service as of 11 a.m. GMT/6 a.m. ET. For a full schedule of news and events, go to our editorial calendar on Reuters Connect </p><p>   TOP STORIES</p><p>   GLOBAL</p><p>   MYANMAR-POLITICS-PROTEST</p><p>   Protests sweep Myanmar to oppose coup, support Suu Kyi</p><p>   Tens of thousands of people rallied across Myanmar on Sunday to denounce last week's coup and demand the release of elected leader Aung San Suu Kyi, in the biggest protests since the 2007 Saffron Revolution that helped lead to democratic reforms.</p><p>    INDIA-DISASTER</p><p>   Himalayan glacier bursts in India, 100-150 feared dead in floods</p><p>   As many as 150 people were feared dead in northern India after a Himalayan glacier broke and crashed into a dam early on Sunday, with floods forcing the evacuation of villages downstream.</p><p>   U.S.</p><p>   USA-IMMIGRATION-CENTRALAMERICA</p><p>   Biden administration suspends Trump asylum deals with El Salvador, Guatemala, Honduras</p><p>   The Biden administration said on Saturday it was immediately suspending Trump-era asylum agreements with El Salvador, Guatemala and Honduras, part of a bid to undo his Republican predecessor's hardline immigration policies.</p><p>    USA-IMMIGRATION-MAYORKAS</p><p>   Biden's Homeland Security czar vows to fight domestic terrorism</p><p>   U.S. Homeland Security chief Alejandro Mayorkas, who last week became the first Latino and immigrant to hold the post, on Saturday reaffirmed his resolve to fight domestic terrorism, <a href=\"https://laohu8.com/S/AONE\">one</a> of the greatest threats to the United States.</p><p>    BUSINESS</p><p>   AMAZON-ENGINES-NATURAL-GAS</p><p>   Exclusive: Amazon orders hundreds of trucks that run on natural gas</p><p>   Amazon.com Inc has ordered hundreds of trucks that run on compressed natural gas as it tests ways to shift its U.S. fleet away from heavier polluting trucks, the company told Reuters on Friday.</p><p>    ECB-POLICY-LAGARDE</p><p>   Euro zone recovery delayed, to gather pace from mid-year: Lagarde</p><p>   Europe's recovery from a recession induced by the COVID-19 pandemic has been somewhat delayed but should pick up pace from mid-year, European Central Bank President Christine Lagarde said in comments published by a French newspaper on Sunday.</p><p>    ENTERTAINMENT</p><p>   PEOPLE-JENNIFER-LAWRENCE</p><p>   Jennifer Lawrence reported hurt by flying glass on movie set</p><p>   Oscar winner Jennifer Lawrence was hit near the eye by flying glass while filming her new movie in Boston, celebrity website TMZ and the Boston Globe reported on Friday.</p><p>    PEOPLE-CHRISTOPHER-PLUMMER</p><p>   Christopher Plummer, 'Sound of Music' star of stage and screen, dead at 91</p><p>   Christopher Plummer, a patrician Canadian who starred as widower Captain von Trapp opposite Julie Andrews in the blockbuster 1965 musical \"The Sound Of Music\" and in 2012 became the oldest actor to win an Oscar, has died at 91, his longtime friend and manager said on Friday.</p><p>   SPORTS    </p><p>   BASKETBALL-NBA-ROUNDUP</p><p>   NBA roundup: Stephen Curry scores 57 points in loss to Mavs</p><p>   Stephen Curry won his individual duel with Luka Doncic but the host Dallas Mavericks captured the team competition over the Golden State Warriors in a wild 134-132 victory Saturday night.</p><p>    TENNIS-AUSOPEN-PREVIEW</p><p>   Australian Open ready to launch after pandemic palpitations</p><p>   After a three-week delay, a massive logistical mission and a handful of health scares, a very different Australian Open gets underway on Monday with pandemic protocols providing a backdrop of caution to the action on court.</p><p>    UPCOMING </p><p>   BUSINESS / ECONOMICS </p><p>   GLOBAL-OIL/HEDGEFUNDS  </p><p>   FOCUS-Hedge funds bet on 'big comeback' for oil after pandemic hobbles producers </p><p>   Hedge funds are turning bullish on oil once again, betting the energy industry's environmental focus has severely damaged companies' ability to ramp up production when demand returns, which would push prices to multi-year highs and keep them that way for two years or more. </p><p>   7 Feb 09:00 ET / 14:00 GMT </p><p>   SCIENCE / TECHNOLOGY </p><p>   HEALTH-CORONAVIRUS/  </p><p>   Czech government decides on emergency state extension </p><p>   The Czech government decides on another emergency state extension. The measure provides the executive with legal framework for its actions against the coronavirus pandemic, including deployment of troops to assist healthcare or limits on people's movement. </p><p>   8 Feb  </p><p>   SPACE-EXPLORATION/BEZOS (PIX)  </p><p>   An unleashed Jeff Bezos will turn up the heat on space venture Blue Origin </p><p>   Untethered from daily obligations at Amazon.com Inc</p><p> , Jeff Bezos is expected to turn up the heat on his space venture, Blue Origin, as it faces a pivotal year and fierce competition from Elon Musk's SpaceX. </p><p>   8 Feb  </p><p>   HEALTH-CORONAVIRUS/WHO BRIEFING <a href=\"https://laohu8.com/S/TV\">$(TV)$</a>  </p><p>   WHO chief Tedros and other officials due to give press conference </p><p>   Tedros Adhanom Ghebreyesus, director-general of the World Health Organization (WHO), to give press conference on the latest developments in the COVID-19 pandemic, which also follows the first week of the WHO's Executive Board being held through Jan 26. </p><p>   8 Feb  </p><p>   HEALTH-CORONAVIRUS/SCALPERS  </p><p>   Walgreens, CVS beef up protections against threat of bot attacks on vaccine program </p><p>   U.S. retailers and pharmacies like Walgreens and CVS Health are preparing for a fresh round of bot attacks by scalpers hoping to snap up Covid-19 vaccine appointments as they have done hoarding Sony PlayStation 5s and Nike sneakers. </p><p>   8 Feb  </p><p>   EU-RECOVERY/LAGARDE  </p><p>   ECB head Lagarde debates economic effects of pandemic in EU Parliament </p><p>   The head of the ECB Christine Lagarde debates mitigating the pandemic’s economic effects with European lawmakers who will assess what the ECB can do within its mandate, including exploring novel tools. </p><p>   8 Feb  </p><p>   SPORTS </p><p>   FOOTBALL-NFL-SUPERBOWL/LOSANGELES  </p><p>   NFL-Los Angeles hoping to host 'normal' Super Bowl next year</p><p>   As the curtains close on the COVID-impacted Super Bowl in Tampa, Los Angeles is hoping for a return to \"normal\" when it hosts the championship game at the $5 billion SoFi stadium, which opened in Inglewood last year. </p><p>   8 Feb  </p><p>   CRIME / LAW / JUSTICE </p><p>   ISRAEL-NETANYAHU/TRIAL-EXPLAINER (PIX) (TV)  </p><p>   Israel's Netanyahu on trial for corruption </p><p>   EXPLAINER - Prime Minister Benjamin Netanyahu's trial resumes on Monday, when Israel's longest serving leader will have to enter his plea to the corruption charges against him. This brief explainer lays out the charges facing Israel's first sitting prime minister to have been indicted, as well as the possible scenarios that may ensue. </p><p>   8 Feb  </p><p>   POLITICS / INTERNATIONAL AFFAIRS </p><p>   SOMALIA-ELECTION/  </p><p>   POSTPONED - Elections scheduled to be held in Somalia </p><p>   A parliamentary election is due to be held in war-ravaged Somalia, where the internationally backed federal government is battling the al Qaeda-linked al Shabab insurgency. Legislators will choose the next president, but opposition members have accused the government of packing the election board with government allies. </p><p>   8 Feb   </p><p>   USA-TRUMP/IMPEACHMENT (PIX) (TV)  </p><p>   U.S. Congress prepares for Trump's second impeachment </p><p>   The U.S. Congress on Monday prepares for a historic first -- the impeachment trial of former President Donald Trump after he has left office, on a charge of inciting insurrection in a fiery speech to his supporters before the deadly storming of the U.S. Capitol. Trump and the House of Representatives file final written arguments before the start of a trial in the Senate that could result in Trump being banned from holding office again.</p><p>   8 Feb  </p><p>   CONFLICTS / WAR / PEACE </p><p>   NORTHKOREA-MILITARY/ (TV)  </p><p>   North Korea to celebrate the founding of its military </p><p>   North Korea to celebrate the founding of its army, after its leader Kim Jong Un had called for increased military power and greater nuclear war deterrence last month. Kim attended a military parade in 2018, and met soldiers and watched a concert in 2019 to mark the occasion. </p><p>   8 Feb</p><p>   SUPER BOWL-RATINGS/  </p><p>   Spot news coverage of Super Bowl TV ratings </p><p>   Reuters will report on the TV ratings for the Feb. 7 Super Bowl, which ViacomCBS-owned CBS is broadcasting. </p><p>   8 Feb   </p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>REUTERS NEWS SCHEDULE AT 11 a.m. GMT/6 a.m. ET</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nREUTERS NEWS SCHEDULE AT 11 a.m. GMT/6 a.m. ET\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-07 19:17</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>Here are the top stories and upcoming coverage plans for Reuters text service as of 11 a.m. GMT/6 a.m. ET. For a full schedule of news and events, go to our editorial calendar on Reuters Connect </p><p>   TOP STORIES</p><p>   GLOBAL</p><p>   MYANMAR-POLITICS-PROTEST</p><p>   Protests sweep Myanmar to oppose coup, support Suu Kyi</p><p>   Tens of thousands of people rallied across Myanmar on Sunday to denounce last week's coup and demand the release of elected leader Aung San Suu Kyi, in the biggest protests since the 2007 Saffron Revolution that helped lead to democratic reforms.</p><p>    INDIA-DISASTER</p><p>   Himalayan glacier bursts in India, 100-150 feared dead in floods</p><p>   As many as 150 people were feared dead in northern India after a Himalayan glacier broke and crashed into a dam early on Sunday, with floods forcing the evacuation of villages downstream.</p><p>   U.S.</p><p>   USA-IMMIGRATION-CENTRALAMERICA</p><p>   Biden administration suspends Trump asylum deals with El Salvador, Guatemala, Honduras</p><p>   The Biden administration said on Saturday it was immediately suspending Trump-era asylum agreements with El Salvador, Guatemala and Honduras, part of a bid to undo his Republican predecessor's hardline immigration policies.</p><p>    USA-IMMIGRATION-MAYORKAS</p><p>   Biden's Homeland Security czar vows to fight domestic terrorism</p><p>   U.S. Homeland Security chief Alejandro Mayorkas, who last week became the first Latino and immigrant to hold the post, on Saturday reaffirmed his resolve to fight domestic terrorism, <a href=\"https://laohu8.com/S/AONE\">one</a> of the greatest threats to the United States.</p><p>    BUSINESS</p><p>   AMAZON-ENGINES-NATURAL-GAS</p><p>   Exclusive: Amazon orders hundreds of trucks that run on natural gas</p><p>   Amazon.com Inc has ordered hundreds of trucks that run on compressed natural gas as it tests ways to shift its U.S. fleet away from heavier polluting trucks, the company told Reuters on Friday.</p><p>    ECB-POLICY-LAGARDE</p><p>   Euro zone recovery delayed, to gather pace from mid-year: Lagarde</p><p>   Europe's recovery from a recession induced by the COVID-19 pandemic has been somewhat delayed but should pick up pace from mid-year, European Central Bank President Christine Lagarde said in comments published by a French newspaper on Sunday.</p><p>    ENTERTAINMENT</p><p>   PEOPLE-JENNIFER-LAWRENCE</p><p>   Jennifer Lawrence reported hurt by flying glass on movie set</p><p>   Oscar winner Jennifer Lawrence was hit near the eye by flying glass while filming her new movie in Boston, celebrity website TMZ and the Boston Globe reported on Friday.</p><p>    PEOPLE-CHRISTOPHER-PLUMMER</p><p>   Christopher Plummer, 'Sound of Music' star of stage and screen, dead at 91</p><p>   Christopher Plummer, a patrician Canadian who starred as widower Captain von Trapp opposite Julie Andrews in the blockbuster 1965 musical \"The Sound Of Music\" and in 2012 became the oldest actor to win an Oscar, has died at 91, his longtime friend and manager said on Friday.</p><p>   SPORTS    </p><p>   BASKETBALL-NBA-ROUNDUP</p><p>   NBA roundup: Stephen Curry scores 57 points in loss to Mavs</p><p>   Stephen Curry won his individual duel with Luka Doncic but the host Dallas Mavericks captured the team competition over the Golden State Warriors in a wild 134-132 victory Saturday night.</p><p>    TENNIS-AUSOPEN-PREVIEW</p><p>   Australian Open ready to launch after pandemic palpitations</p><p>   After a three-week delay, a massive logistical mission and a handful of health scares, a very different Australian Open gets underway on Monday with pandemic protocols providing a backdrop of caution to the action on court.</p><p>    UPCOMING </p><p>   BUSINESS / ECONOMICS </p><p>   GLOBAL-OIL/HEDGEFUNDS  </p><p>   FOCUS-Hedge funds bet on 'big comeback' for oil after pandemic hobbles producers </p><p>   Hedge funds are turning bullish on oil once again, betting the energy industry's environmental focus has severely damaged companies' ability to ramp up production when demand returns, which would push prices to multi-year highs and keep them that way for two years or more. </p><p>   7 Feb 09:00 ET / 14:00 GMT </p><p>   SCIENCE / TECHNOLOGY </p><p>   HEALTH-CORONAVIRUS/  </p><p>   Czech government decides on emergency state extension </p><p>   The Czech government decides on another emergency state extension. The measure provides the executive with legal framework for its actions against the coronavirus pandemic, including deployment of troops to assist healthcare or limits on people's movement. </p><p>   8 Feb  </p><p>   SPACE-EXPLORATION/BEZOS (PIX)  </p><p>   An unleashed Jeff Bezos will turn up the heat on space venture Blue Origin </p><p>   Untethered from daily obligations at Amazon.com Inc</p><p> , Jeff Bezos is expected to turn up the heat on his space venture, Blue Origin, as it faces a pivotal year and fierce competition from Elon Musk's SpaceX. </p><p>   8 Feb  </p><p>   HEALTH-CORONAVIRUS/WHO BRIEFING <a href=\"https://laohu8.com/S/TV\">$(TV)$</a>  </p><p>   WHO chief Tedros and other officials due to give press conference </p><p>   Tedros Adhanom Ghebreyesus, director-general of the World Health Organization (WHO), to give press conference on the latest developments in the COVID-19 pandemic, which also follows the first week of the WHO's Executive Board being held through Jan 26. </p><p>   8 Feb  </p><p>   HEALTH-CORONAVIRUS/SCALPERS  </p><p>   Walgreens, CVS beef up protections against threat of bot attacks on vaccine program </p><p>   U.S. retailers and pharmacies like Walgreens and CVS Health are preparing for a fresh round of bot attacks by scalpers hoping to snap up Covid-19 vaccine appointments as they have done hoarding Sony PlayStation 5s and Nike sneakers. </p><p>   8 Feb  </p><p>   EU-RECOVERY/LAGARDE  </p><p>   ECB head Lagarde debates economic effects of pandemic in EU Parliament </p><p>   The head of the ECB Christine Lagarde debates mitigating the pandemic’s economic effects with European lawmakers who will assess what the ECB can do within its mandate, including exploring novel tools. </p><p>   8 Feb  </p><p>   SPORTS </p><p>   FOOTBALL-NFL-SUPERBOWL/LOSANGELES  </p><p>   NFL-Los Angeles hoping to host 'normal' Super Bowl next year</p><p>   As the curtains close on the COVID-impacted Super Bowl in Tampa, Los Angeles is hoping for a return to \"normal\" when it hosts the championship game at the $5 billion SoFi stadium, which opened in Inglewood last year. </p><p>   8 Feb  </p><p>   CRIME / LAW / JUSTICE </p><p>   ISRAEL-NETANYAHU/TRIAL-EXPLAINER (PIX) (TV)  </p><p>   Israel's Netanyahu on trial for corruption </p><p>   EXPLAINER - Prime Minister Benjamin Netanyahu's trial resumes on Monday, when Israel's longest serving leader will have to enter his plea to the corruption charges against him. This brief explainer lays out the charges facing Israel's first sitting prime minister to have been indicted, as well as the possible scenarios that may ensue. </p><p>   8 Feb  </p><p>   POLITICS / INTERNATIONAL AFFAIRS </p><p>   SOMALIA-ELECTION/  </p><p>   POSTPONED - Elections scheduled to be held in Somalia </p><p>   A parliamentary election is due to be held in war-ravaged Somalia, where the internationally backed federal government is battling the al Qaeda-linked al Shabab insurgency. Legislators will choose the next president, but opposition members have accused the government of packing the election board with government allies. </p><p>   8 Feb   </p><p>   USA-TRUMP/IMPEACHMENT (PIX) (TV)  </p><p>   U.S. Congress prepares for Trump's second impeachment </p><p>   The U.S. Congress on Monday prepares for a historic first -- the impeachment trial of former President Donald Trump after he has left office, on a charge of inciting insurrection in a fiery speech to his supporters before the deadly storming of the U.S. Capitol. Trump and the House of Representatives file final written arguments before the start of a trial in the Senate that could result in Trump being banned from holding office again.</p><p>   8 Feb  </p><p>   CONFLICTS / WAR / PEACE </p><p>   NORTHKOREA-MILITARY/ (TV)  </p><p>   North Korea to celebrate the founding of its military </p><p>   North Korea to celebrate the founding of its army, after its leader Kim Jong Un had called for increased military power and greater nuclear war deterrence last month. Kim attended a military parade in 2018, and met soldiers and watched a concert in 2019 to mark the occasion. </p><p>   8 Feb</p><p>   SUPER BOWL-RATINGS/  </p><p>   Spot news coverage of Super Bowl TV ratings </p><p>   Reuters will report on the TV ratings for the Feb. 7 Super Bowl, which ViacomCBS-owned CBS is broadcasting. </p><p>   8 Feb   </p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QNETCN":"纳斯达克中美互联网老虎指数","03086":"华夏纳指","09086":"华夏纳指-U","AMZN":"亚马逊"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2109704729","content_text":"Here are the top stories and upcoming coverage plans for Reuters text service as of 11 a.m. GMT/6 a.m. ET. For a full schedule of news and events, go to our editorial calendar on Reuters Connect    TOP STORIES   GLOBAL   MYANMAR-POLITICS-PROTEST   Protests sweep Myanmar to oppose coup, support Suu Kyi   Tens of thousands of people rallied across Myanmar on Sunday to denounce last week's coup and demand the release of elected leader Aung San Suu Kyi, in the biggest protests since the 2007 Saffron Revolution that helped lead to democratic reforms.    INDIA-DISASTER   Himalayan glacier bursts in India, 100-150 feared dead in floods   As many as 150 people were feared dead in northern India after a Himalayan glacier broke and crashed into a dam early on Sunday, with floods forcing the evacuation of villages downstream.   U.S.   USA-IMMIGRATION-CENTRALAMERICA   Biden administration suspends Trump asylum deals with El Salvador, Guatemala, Honduras   The Biden administration said on Saturday it was immediately suspending Trump-era asylum agreements with El Salvador, Guatemala and Honduras, part of a bid to undo his Republican predecessor's hardline immigration policies.    USA-IMMIGRATION-MAYORKAS   Biden's Homeland Security czar vows to fight domestic terrorism   U.S. Homeland Security chief Alejandro Mayorkas, who last week became the first Latino and immigrant to hold the post, on Saturday reaffirmed his resolve to fight domestic terrorism, one of the greatest threats to the United States.    BUSINESS   AMAZON-ENGINES-NATURAL-GAS   Exclusive: Amazon orders hundreds of trucks that run on natural gas   Amazon.com Inc has ordered hundreds of trucks that run on compressed natural gas as it tests ways to shift its U.S. fleet away from heavier polluting trucks, the company told Reuters on Friday.    ECB-POLICY-LAGARDE   Euro zone recovery delayed, to gather pace from mid-year: Lagarde   Europe's recovery from a recession induced by the COVID-19 pandemic has been somewhat delayed but should pick up pace from mid-year, European Central Bank President Christine Lagarde said in comments published by a French newspaper on Sunday.    ENTERTAINMENT   PEOPLE-JENNIFER-LAWRENCE   Jennifer Lawrence reported hurt by flying glass on movie set   Oscar winner Jennifer Lawrence was hit near the eye by flying glass while filming her new movie in Boston, celebrity website TMZ and the Boston Globe reported on Friday.    PEOPLE-CHRISTOPHER-PLUMMER   Christopher Plummer, 'Sound of Music' star of stage and screen, dead at 91   Christopher Plummer, a patrician Canadian who starred as widower Captain von Trapp opposite Julie Andrews in the blockbuster 1965 musical \"The Sound Of Music\" and in 2012 became the oldest actor to win an Oscar, has died at 91, his longtime friend and manager said on Friday.   SPORTS       BASKETBALL-NBA-ROUNDUP   NBA roundup: Stephen Curry scores 57 points in loss to Mavs   Stephen Curry won his individual duel with Luka Doncic but the host Dallas Mavericks captured the team competition over the Golden State Warriors in a wild 134-132 victory Saturday night.    TENNIS-AUSOPEN-PREVIEW   Australian Open ready to launch after pandemic palpitations   After a three-week delay, a massive logistical mission and a handful of health scares, a very different Australian Open gets underway on Monday with pandemic protocols providing a backdrop of caution to the action on court.    UPCOMING    BUSINESS / ECONOMICS    GLOBAL-OIL/HEDGEFUNDS     FOCUS-Hedge funds bet on 'big comeback' for oil after pandemic hobbles producers    Hedge funds are turning bullish on oil once again, betting the energy industry's environmental focus has severely damaged companies' ability to ramp up production when demand returns, which would push prices to multi-year highs and keep them that way for two years or more.    7 Feb 09:00 ET / 14:00 GMT    SCIENCE / TECHNOLOGY    HEALTH-CORONAVIRUS/     Czech government decides on emergency state extension    The Czech government decides on another emergency state extension. The measure provides the executive with legal framework for its actions against the coronavirus pandemic, including deployment of troops to assist healthcare or limits on people's movement.    8 Feb     SPACE-EXPLORATION/BEZOS (PIX)     An unleashed Jeff Bezos will turn up the heat on space venture Blue Origin    Untethered from daily obligations at Amazon.com Inc , Jeff Bezos is expected to turn up the heat on his space venture, Blue Origin, as it faces a pivotal year and fierce competition from Elon Musk's SpaceX.    8 Feb     HEALTH-CORONAVIRUS/WHO BRIEFING $(TV)$     WHO chief Tedros and other officials due to give press conference    Tedros Adhanom Ghebreyesus, director-general of the World Health Organization (WHO), to give press conference on the latest developments in the COVID-19 pandemic, which also follows the first week of the WHO's Executive Board being held through Jan 26.    8 Feb     HEALTH-CORONAVIRUS/SCALPERS     Walgreens, CVS beef up protections against threat of bot attacks on vaccine program    U.S. retailers and pharmacies like Walgreens and CVS Health are preparing for a fresh round of bot attacks by scalpers hoping to snap up Covid-19 vaccine appointments as they have done hoarding Sony PlayStation 5s and Nike sneakers.    8 Feb     EU-RECOVERY/LAGARDE     ECB head Lagarde debates economic effects of pandemic in EU Parliament    The head of the ECB Christine Lagarde debates mitigating the pandemic’s economic effects with European lawmakers who will assess what the ECB can do within its mandate, including exploring novel tools.    8 Feb     SPORTS    FOOTBALL-NFL-SUPERBOWL/LOSANGELES     NFL-Los Angeles hoping to host 'normal' Super Bowl next year   As the curtains close on the COVID-impacted Super Bowl in Tampa, Los Angeles is hoping for a return to \"normal\" when it hosts the championship game at the $5 billion SoFi stadium, which opened in Inglewood last year.    8 Feb     CRIME / LAW / JUSTICE    ISRAEL-NETANYAHU/TRIAL-EXPLAINER (PIX) (TV)     Israel's Netanyahu on trial for corruption    EXPLAINER - Prime Minister Benjamin Netanyahu's trial resumes on Monday, when Israel's longest serving leader will have to enter his plea to the corruption charges against him. This brief explainer lays out the charges facing Israel's first sitting prime minister to have been indicted, as well as the possible scenarios that may ensue.    8 Feb     POLITICS / INTERNATIONAL AFFAIRS    SOMALIA-ELECTION/     POSTPONED - Elections scheduled to be held in Somalia    A parliamentary election is due to be held in war-ravaged Somalia, where the internationally backed federal government is battling the al Qaeda-linked al Shabab insurgency. Legislators will choose the next president, but opposition members have accused the government of packing the election board with government allies.    8 Feb      USA-TRUMP/IMPEACHMENT (PIX) (TV)     U.S. Congress prepares for Trump's second impeachment    The U.S. Congress on Monday prepares for a historic first -- the impeachment trial of former President Donald Trump after he has left office, on a charge of inciting insurrection in a fiery speech to his supporters before the deadly storming of the U.S. Capitol. Trump and the House of Representatives file final written arguments before the start of a trial in the Senate that could result in Trump being banned from holding office again.   8 Feb     CONFLICTS / WAR / PEACE    NORTHKOREA-MILITARY/ (TV)     North Korea to celebrate the founding of its military    North Korea to celebrate the founding of its army, after its leader Kim Jong Un had called for increased military power and greater nuclear war deterrence last month. Kim attended a military parade in 2018, and met soldiers and watched a concert in 2019 to mark the occasion.    8 Feb   SUPER BOWL-RATINGS/     Spot news coverage of Super Bowl TV ratings    Reuters will report on the TV ratings for the Feb. 7 Super Bowl, which ViacomCBS-owned CBS is broadcasting.    8 Feb","news_type":1},"isVote":1,"tweetType":1,"viewCount":313,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9092109423,"gmtCreate":1644545256524,"gmtModify":1676533939595,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567658644109643","idStr":"3567658644109643"},"themes":[],"htmlText":"Join now!","listText":"Join now!","text":"Join now!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9092109423","repostId":"9004448317","repostType":1,"repost":{"id":9004448317,"gmtCreate":1642676525258,"gmtModify":1676533734534,"author":{"id":"3527667667103859","authorId":"3527667667103859","name":"TigerEvents","avatar":"https://community-static.tradeup.com/news/c266ef25181ace18bec1262357bbe1a8","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3527667667103859","idStr":"3527667667103859"},"themes":[],"title":"Join Tiger Ski Championship, Win a Bonus of Up to USD 2022","htmlText":"2022 is the Year of Tiger in Chinese lunar calendar, it’s also a special year for Tiger Brokers. To celebrate the special year, we want to invite you to join the ski game presented by Tiger Brokers specially, and it’s very easy and interesting game for users to play. Join the game and win a bonus of up to USD 2022 and limited-edition Tiger Toys Spring Festival and Winter Olympic are both on the way, open your Tiger Trade App and play the ski game with us, win golden medals as many as you can! You could have chance to try Lucky Draw when you win medals.The more medal you win, the bigger bonus you may win! Big Rewards are as follow: <a href=\"https://www.tigerbrokers.com.sg/activity/market/2022/happy-new-year/#/\" target=\"_blank\">Click to Join the Game</a>","listText":"2022 is the Year of Tiger in Chinese lunar calendar, it’s also a special year for Tiger Brokers. To celebrate the special year, we want to invite you to join the ski game presented by Tiger Brokers specially, and it’s very easy and interesting game for users to play. Join the game and win a bonus of up to USD 2022 and limited-edition Tiger Toys Spring Festival and Winter Olympic are both on the way, open your Tiger Trade App and play the ski game with us, win golden medals as many as you can! You could have chance to try Lucky Draw when you win medals.The more medal you win, the bigger bonus you may win! Big Rewards are as follow: <a href=\"https://www.tigerbrokers.com.sg/activity/market/2022/happy-new-year/#/\" target=\"_blank\">Click to Join the Game</a>","text":"2022 is the Year of Tiger in Chinese lunar calendar, it’s also a special year for Tiger Brokers. To celebrate the special year, we want to invite you to join the ski game presented by Tiger Brokers specially, and it’s very easy and interesting game for users to play. Join the game and win a bonus of up to USD 2022 and limited-edition Tiger Toys Spring Festival and Winter Olympic are both on the way, open your Tiger Trade App and play the ski game with us, win golden medals as many as you can! You could have chance to try Lucky Draw when you win medals.The more medal you win, the bigger bonus you may win! Big Rewards are as follow: Click to Join the Game","images":[{"img":"https://static.tigerbbs.com/a7b44fa056439fb4010fa55e163d27c3","width":"750","height":"1726"}],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9004448317","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":2,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":230,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":317026310,"gmtCreate":1612400012630,"gmtModify":1704870635210,"author":{"id":"3567658644109643","authorId":"3567658644109643","name":"JazzyTazzy","avatar":"https://static.tigerbbs.com/cd4a9dd018fb8d987d99b520851b607a","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"authorIdStr":"3567658644109643","idStr":"3567658644109643"},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/317026310","repostId":"2108796672","repostType":2,"repost":{"id":"2108796672","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1612396860,"share":"https://ttm.financial/m/news/2108796672?lang=&edition=fundamental","pubTime":"2021-02-04 08:01","market":"us","language":"en","title":"Britain trial to test combining Pfizer and AstraZeneca vaccines in two-shot regimen","url":"https://stock-news.laohu8.com/highlight/detail?id=2108796672","media":"Reuters","summary":"LONDON, Feb 4 (Reuters) - Britain on Thursday launched a trial to assess the immune responses genera","content":"<html><body><p>LONDON, Feb 4 (Reuters) - Britain on Thursday launched a trial to assess the immune responses generated if doses of the COVID-19 vaccines from Pfizer Inc    and <a href=\"https://laohu8.com/S/AZNCF\">AstraZeneca Plc</a></p><p>  are combined in a two-shot schedule.    </p><p>   The British researchers behind the trial said data on vaccinating people with the two different types of coronavirus vaccines could help understanding of whether shots can be rolled out with greater flexibility around the world. Initial data on immune responses is expected to be generated around June.    </p><p>   The trial will examine the immune responses of an initial dose of Pfizer vaccine followed by a booster of AstraZeneca's, as well as vice versa, with intervals of 4 and 12 weeks. </p><p>   Both the mRNA shot developed by Pfizer and Biontech    and the adenovirus viral vector vaccine developed by Oxford University and AstraZeneca are currently being rolled out in Britain, with a 12-week gap between two doses of the same vaccine. </p><p>   It is expected more vaccines will be added to the trial when they are approved and rolled out.</p><p>   Recruitment for the study starts on Thursday, with over 800 participants expected to take part, the researchers said. That makes it much smaller than the clinical trials that have been used to determine efficacy of the vaccines individually.</p><p>   The trial will not assess the overall efficacy of the shot combinations, but researchers will measure antibody and T-cell responses, as well as monitor for any unexpected side effects.</p><p>   Matthew Snape, an Oxford vaccinologist who is leading the trial, said initial results could inform vaccine deployment in the second half of the year.</p><p>   \"We will get some results through, we expect, by June or thereabouts that will inform the use of booster doses in the general population,\" he told reporters.</p><p>   The trial is looking to recruit people over the age of 50 who may be at higher risk than younger people and have not been vaccinated already.</p><p>   AstraZeneca's shot is also being tested in combination with Russia's Sputnik V vaccine, and British drugmaker's research chief has said more studies on combining vaccines should be done.  </p><p> (Reporting by Alistair Smout Editing by Bill Berkrot)</p><p>((alistair.smout@thomsonreuters.com; +44 207 542 7064; Reuters Messaging: alistair.smout.thomsonreuters.com@reuters.net))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Britain trial to test combining Pfizer and AstraZeneca vaccines in two-shot regimen</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBritain trial to test combining Pfizer and AstraZeneca vaccines in two-shot regimen\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-02-04 08:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>LONDON, Feb 4 (Reuters) - Britain on Thursday launched a trial to assess the immune responses generated if doses of the COVID-19 vaccines from Pfizer Inc    and <a href=\"https://laohu8.com/S/AZNCF\">AstraZeneca Plc</a></p><p>  are combined in a two-shot schedule.    </p><p>   The British researchers behind the trial said data on vaccinating people with the two different types of coronavirus vaccines could help understanding of whether shots can be rolled out with greater flexibility around the world. Initial data on immune responses is expected to be generated around June.    </p><p>   The trial will examine the immune responses of an initial dose of Pfizer vaccine followed by a booster of AstraZeneca's, as well as vice versa, with intervals of 4 and 12 weeks. </p><p>   Both the mRNA shot developed by Pfizer and Biontech    and the adenovirus viral vector vaccine developed by Oxford University and AstraZeneca are currently being rolled out in Britain, with a 12-week gap between two doses of the same vaccine. </p><p>   It is expected more vaccines will be added to the trial when they are approved and rolled out.</p><p>   Recruitment for the study starts on Thursday, with over 800 participants expected to take part, the researchers said. That makes it much smaller than the clinical trials that have been used to determine efficacy of the vaccines individually.</p><p>   The trial will not assess the overall efficacy of the shot combinations, but researchers will measure antibody and T-cell responses, as well as monitor for any unexpected side effects.</p><p>   Matthew Snape, an Oxford vaccinologist who is leading the trial, said initial results could inform vaccine deployment in the second half of the year.</p><p>   \"We will get some results through, we expect, by June or thereabouts that will inform the use of booster doses in the general population,\" he told reporters.</p><p>   The trial is looking to recruit people over the age of 50 who may be at higher risk than younger people and have not been vaccinated already.</p><p>   AstraZeneca's shot is also being tested in combination with Russia's Sputnik V vaccine, and British drugmaker's research chief has said more studies on combining vaccines should be done.  </p><p> (Reporting by Alistair Smout Editing by Bill Berkrot)</p><p>((alistair.smout@thomsonreuters.com; +44 207 542 7064; Reuters Messaging: alistair.smout.thomsonreuters.com@reuters.net))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2108796672","content_text":"LONDON, Feb 4 (Reuters) - Britain on Thursday launched a trial to assess the immune responses generated if doses of the COVID-19 vaccines from Pfizer Inc    and AstraZeneca Plc  are combined in a two-shot schedule.       The British researchers behind the trial said data on vaccinating people with the two different types of coronavirus vaccines could help understanding of whether shots can be rolled out with greater flexibility around the world. Initial data on immune responses is expected to be generated around June.       The trial will examine the immune responses of an initial dose of Pfizer vaccine followed by a booster of AstraZeneca's, as well as vice versa, with intervals of 4 and 12 weeks.    Both the mRNA shot developed by Pfizer and Biontech    and the adenovirus viral vector vaccine developed by Oxford University and AstraZeneca are currently being rolled out in Britain, with a 12-week gap between two doses of the same vaccine.    It is expected more vaccines will be added to the trial when they are approved and rolled out.   Recruitment for the study starts on Thursday, with over 800 participants expected to take part, the researchers said. That makes it much smaller than the clinical trials that have been used to determine efficacy of the vaccines individually.   The trial will not assess the overall efficacy of the shot combinations, but researchers will measure antibody and T-cell responses, as well as monitor for any unexpected side effects.   Matthew Snape, an Oxford vaccinologist who is leading the trial, said initial results could inform vaccine deployment in the second half of the year.   \"We will get some results through, we expect, by June or thereabouts that will inform the use of booster doses in the general population,\" he told reporters.   The trial is looking to recruit people over the age of 50 who may be at higher risk than younger people and have not been vaccinated already.   AstraZeneca's shot is also being tested in combination with Russia's Sputnik V vaccine, and British drugmaker's research chief has said more studies on combining vaccines should be done.   (Reporting by Alistair Smout Editing by Bill Berkrot)((alistair.smout@thomsonreuters.com; +44 207 542 7064; Reuters Messaging: alistair.smout.thomsonreuters.com@reuters.net))","news_type":1},"isVote":1,"tweetType":1,"viewCount":358,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}